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Zusammenfassung 
 
Candida albicans ist ein weit verbreiteter humaner bedingt-pathogener 
Krankheitserreger und ist oft auf der Haut, im Genitalbereich und im natürlicherweise 
Verdauungstrakt zu finden. Candida albicans kann sich zu einem pathogenen Pilz 
entwickeln wenn das Immunsystem geschwächt ist, der Hormonhaushalt oder die 
Schleimhautbarriere nicht intakt sind. Eine Infektion mit Candida albicans bei 
immunsupprimierten Patienten kann zu lebensbedrohlichen systemischen Infektionen 
führen. Bei der Infektion spielen vor allem die Zellwand und Zellwandbestandteile des 
Pilzes eine wichtige Rolle. Die Zellwand ist ein komplexes Netzwerk aus Glucan, Chitin, 
Mannan und vielen Proteinen.  Die Zellwand vermittelt die ersten Wechselwirkungen 
zwischen dem Pathogen und dem Wirt. Pathogene werden im Organismus von den Zellen 
des angeborenen Immunsystems phagozytiert und getötet oder Zellen des adaptiven 
Immunsystems, den T-Zellen, präsentiert, was einen wichtigen Mechanismus in der 
Abwehr gegen Mikroorganismen darstellt. In den Phagozyten werden unter anderem 
reaktive Sauerstoffmoleküle (ROS) produziert, die Pathogene töten. Da Candida albicans 
für Patienten mit einem geschwächten Immunsystem eine Lebensbedrohung darstellt,  ist 
es sehr wichtig dessen Virulenzfaktoren zu erforschen.  
Die Superoxid Dismutase Sod5 ist ein Protein, das den Candida albicans 
Zellen hilft gegen die Makrophagen zu arbeiten, indem es die reaktiven Sauerstoffradikale 
neutralisieren kann. Candida albicans Stämme ohne Sod5 haben im Vergleich zum 
Wildtyp in der interaktion mit Immunzellen eine niedrigere Überlebensrate. Außerdem 
konnten bei einer Interaktion zwischen Makrophagen und dem sod5Δ/Δ Deletionsstamm 
erhöhte ROS Werte gemessen werden.  
Wir verwendeten zwei verschiedene genetische Methoden um die genaue 
Lokalisierung des Proteins in der Zelle zu studieren. Einerseits, sollten spezifische 
Antikörper gegen das Protein produziert werden mit welchen das Protein immunologisch 
detektiert werden kann. Andererseits, sollte Sod5 mit einem „Green Fluoreszenz Protein“ 
fusioniert werden um es in der Zelle mikroskopisch sichtbar zu machen. Es ist uns 
gelungen zu zeigen, dass das Protein an der Candida albicans Zelloberfläche lokalisiert 
ist.  
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I. Introduction 
 
I. 1. The Candida species as opportunistic human fungal 
pathogens 
 
Candida spp. belong to the phylum Ascomycota, which includes a variety of 
different pathogenic fungi. The Candida genus consists of different pathogenic and non-
pathogenic species. There are two types of pathogenic fungi: fungi as a primary 
pathogens and opportunistic pathogens. Primary pathogens can cause human disease 
without any known defects in infected individuals. In contrast, changes in the host are 
required for disease caused by opportunistic pathogens (Haynes, 2001). Opportunistic 
pathogens are able to respond very rapidly to environmental changes in the host and can 
become life-threatening, especially in immunocompromised patients, including individuals 
after treatment with broad-spectrum of antibiotics, after cancer therapy and HIV-positive 
individuals. Some members of Candida genus are important pathogenic species, the most 
common pathogen being Candida albicans (C. albicans). More than 17 different species 
of Candida have been identified as agents of infections (Pfaller and Diekema, 2004). 
However, 95% of all Candida bloodstream infections are caused by C. albicans, 
C.glabrata, C.parapsilosis and C.tropicalis and the remaining 5% are caused by 12 to 14 
other Candida species (Pfaller et al., 2004).  
Under normal conditions C. albicans is a harmless human commensal 
existing in the mouth, mucosal membranes, in gastrointestinal and genitourinary tracts 
and also on the skin. Nevertheless, C. albicans is the most common Candida species 
causing infections. When the immune system is weakened, C. albicans is able to invade 
host tissue and disseminate. This fungus is a major human pathogen that is especially 
virulent to people with a compromised immune system such as cancer therapy patients, 
patients after organ transplantations or coinfected with human immunodeficiency virus, 
cousing mortalities of up to 40%. C. albicans species are the fourth leading cause of 
nosocomial bloodstream infection in the United States (Pfaller and Diekema, 2007). 
This fungus is able to escape the host immune surveilence and in case of 
invasive Candidiasis to penetrate host tissues, to enter the blood stream and to spread to 
to different organs (Mavor et al., 2005). Those virulence properties turn the otherwise 
harmless commensal into an aggressive pathogen. C. albicans can grow in three 
morphological distinct forms: yeast, pseudohyphae and hyphae. The hyphal form is 
suggested to be the invasive, pathogenic form of the fungus (Ruiz-Herrera et al., 2006) 
because it is able to penetrate through the host tissue and to escape from the 
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phagosome. Furthermore, C. albicans forms biofilms on catheters and other medical 
equipments. This may also explain why C. albicans is more pathogenic than Candida 
species that are less able to form biofilms (such as C.glabrata, C.tropicalis and 
C.parapsilosis) (Haynes, 2001). Other known virulence factors in C. albicans are secretion 
of hydrolytic proteinases and lipases for host tissue damaging and phenotypic switching. 
Hence, for example the expression of SAP proteinase genes plays important role in 
disease mediation (Schaller et al., 2000). 
C.glabrata is the second most important opportunistic pathogen of the 
Candida genus. C.glabrata is a haploid yeast unable to form true hyphae. It has been 
shown that C.glabrata is often resistant to fluconazole (Hajjeh et al., 2004) and has the 
ability to rapidly develop resistance to all azoles. For this reason infections with C.glabrata 
are difficult to treat and cause a high mortality in infected immune compromised patients. 
(Fidel et al., 1999) 
C.dubliniensis is identified as an opportunistic human pathogen that is most 
closely related to C. albicans. Like C. albicans, C.dubliniensis can grow in three different 
forms and undergo phenotypic switching (Sullivan et al., 2004). Although, C.dubliniensis is 
less pathogenic, it can causes systemic infections. Studies on C.dubliniensis show that it 
is less able to invade into host epithelial tissues and to form hyphae than C. albicans 
(Stokes et al., 2007) and it doesn’t develop resistance to azole treatment.  These facts 
may explain why C.dubliniensis is less pathogenic than C. albicans.  
C.krusei causes about 2 to 3% of all Candida bloodstream infections (Pfaller 
and Diekema, 2004). Like C.glabrata, C.krusei is more resistant to fluconazole and 
therefore the mortality rate due to C.krusei is high (Panackal et al., 2006; Malani et al., 
2005; Safdar et al., 2001). In general, C.krusei is less pathogen than C.albicans, it is less 
anherent to epithelial surfaces, has less proteolytic potential. In tissues infested with 
C.krusei the fungus shows less penetration into the tissue, compared to other Candida 
spp (Samaranayake and Samaranayake, 1994) 
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I. 2. Cell wall and GPI-anchored proteins 
 
The cell wall plays a very important role in fungal pathogenicity, because it is 
the structure that first comes into contact with the host and is responsible for the cross-talk 
between host and pathogen, also mediating adherence to host cells. Therefore, an 
understanding of the cell wall construction is necessary to understand how it is recognized 
by the immune system. The cell wall provides a protection to Candida species against 
environmental stress like chemicals and biological aggression. On the other side, a 
number of specific proteins responsible for virulence-associated processes are located in 
the cell wall, which also plays important roles in the protection against the host immune 
defence. Moreover, cell wall proteins in C. albicans are also required for virulence.  
The C. albicans cell wall consists of four to eight different layers depending on 
the methods used for the analyses (Poulain et al., 1978) (Fig.I.1). About 80 to 90% of the 
cell wall of C. albicans is composed of carbohydrates. The major polysaccharides of the 
cell wall are branched polymers of glucose consisting of  a network of β-1,3 and β-1,6 
linked β-glucans (50–60%), unbranched polymers of β-1,4 linked N-acetyl-D-glucosamine 
(GlcNAc) containing chitin (0.6–3%)  and polymers of mannose (mannan) which are 
covalently associated with proteins (mannoproteins) (about 40%) (Chaffin et al., 1998;  
Kapteyn et al., 1999; Kapteyn et al., 2000). The skeletal components of the cell wall are β-
glucans and chitin. The mannoproteins are the main material of the cell wall matrix. In 
addition, cell walls contain proteins (6- 25%) and minor amounts of lipids (1 - 7%). A very 
important characteristic of C. albicans is the presence of β-1,2-mannans, which are 
absent in S.cerevisiae. This difference is used by macrophages to distinguish between 
these two species (Fradin, 2000) 
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Fig.I.1. The structure of C. albicans cell wall. The major components of the cell wall are β-(1,3)-glucan and 
chitin (poly-β-(1,4)-N-acetylglucosamine) and these are located towards the inside of the cell wall. The outer 
layer is enriched with cell wall proteins (CWP) that are attached to this skeleton mainly via 
glycosylphosphatidylinositol remnants to β-(1,6)-glucan or via alkali-sensitive linkages to β-(1,3)-glucan. 
(Netea et al., 2008) 
Cell wall proteins can be separated in two classes. Class I proteins are not 
covalently linked to the cell wall and can be extracted with detergents. Class II proteins 
can be extracted only after disruption of polysaccharides structures or by breaking the 
linkages between proteins and polysaccharides. Class III proteins are true cell wall 
proteins; they include glycosylphosphatidylinositol (GPI)-anchored proteins bound to β-
(1,6) glucans in the cell wall (de Nobel and Lipke, 1994), proteins with internal repeats 
(Pir), which are attached via alkaline-soluble linkages (Castillo et al., 2003), as well as 
reducing agents-extractable cell wall proteins (RAE-CWPs) (Moukadiri and Zueco, 2001) 
The genome of C. albicans encodes more than 100 predicted GPI-anchored 
proteins (de Groot et al., 2004). GPI-anchored proteins are the most complex post 
transcriptionaly modified proteins. About 30% of cell wall proteins of C. albicans are GPI-
anchored proteins (Kapteyn et al., 2000). Furthermore, 88% of β-glucanase-extractable 
proteins in the cell walls of C. albicans are GPI-anchored (Kapteyn et al., 2000), GPI 
anchors are complex glycolipids that covalently anchor cell surface proteins to the plasma 
membranes or to the cell wall of eukaryotic cells through a highly branched β-(1,6)-glucan 
linker (Tiede et al., 1999). GPI-anchored proteins are highly glucosylated with mannose-
containing polysaccharides. The carbohydratres can reach up to 90% of the molecular 
mass of the GPI-anchored proteins (Netea et al., 2008). Common features of the 
precursors of GPI-anchored proteins include an N-terminal hydrophobic signal sequence 
that is required for trafficking the protein through secretion pathway, and a C-terminal 
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hydrophobic signal sequence that is required for the attachment of the GPI anchor (Caro 
et al., 1997; Tiede et al., 1999). 
The biosynthesis of GPI anchors occurs in two major steps: preassembly of 
the donor GPI in the ER membrane and attachment of the GPI to the newly synthesized 
peptide after the cleavage from the signal sequence. This complex posttranscriptional 
modification occurs on the C-terminus of the protein. The pathway of GPI assembly and 
attachment is highly conserved, as is the structure of GPI- anchored proteins. They 
consist of the N-terminal signal sequence for localization to endoplasmatic reticulum, a C-
terminal domain for attachment to the ER membrane and the ω site. The ω site, a 
cleavage site of the protein for the future ligation to the GPI anchor, is localized 9 to10 
amino acids before the C-terminal end. There is a linker region on position ω-1 to ω-11 
and a spacer region at position ω+3 to ω+9. These regions are flexible and consist of 
uncharged amino acids (Richard and Plaine, 2007). In yeast, the amino acids on the C-
terminus upstream from the site of GPI anchor addition, functions as a signal sequence 
for attachment of the protein to the plasma membrane or to the cell wall (Frieman and 
Cormack, 2003).  The protein is connected to the GPI-anchor via an amide linkage from 
the phosphoethanol-amine group. The GPI anchor consists of a lipid group, myoinositol 
group, an N-acetylglycosamine group and three mannose residues in mammalian cells. 
Fungal GPI anchors have one additional mannose group attached to the third mannose 
group.  
The biosyntesis of a GPI-anchor (Fig.I.2.) starts with the generation of GlcNAc-
PI on the cytoplasmic side of ER. This step is followed by de-N-acetylation to GlcN-PI that 
occurs on the cytoplasmic side of the ER membrane. The next reactions occur in the 
lumen of the ER; therefore, the GlcN-PI must be flipped across the ER membrane. Once 
inside the lumen, the GlcN-PI is inositol-acylated, inositol-mannosylated and modified by 
phosphoethanolamine. The C-terminal signal sequence from the newly synthesised 
protein localized in the ER is cleaved by GPI-transamidase and the GPI precursor is 
attached (Udenfriend and Kodukula, 1995).  
GPI-anchored proteins are transported via a protein secretion pathway to the 
plasma membrane; some of them become attached to cell wall polysaccharides. As 
already mentioned above, there are C-terminal signals in the sequence of the protein, 
which target the proteins either to the plasma membrane or to the cell wall (Mao et al., 
2008). If the protein has two basic amino acids in the ω-minus side, this protein will be 
localized in the plasma membrane, if those amino acids are replaced with hydrophobic 
amino acids the protein will be inserted into the cell wall. In fungi, the proteins that have to 
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be transported to the cell wall are cleaved within the GPI anchor after the glucosamine. 
Afterwards, proteins are linked to β-1,6-glucans, transported to the cell wall and cross-
linked to β-1,3-glucans (Pittet and Conzelmann, 2007) 
There are also some additional modifications in GPI-proteins which exit the ER 
to be transported to the plasma membrane or to the cell wall. The inositolacyl chain is 
removed and replaced though longer lipid chains, that allows the association with 
membranes. These reactions take place in the ER. 
 
 
Fig.I.2. The different steps of the synthesis and transport of a GPI-anchored protein in yeasts or fungi. 
The first steps of GPI anchor biosynthesis occur in the ER. The attachment of the protein to the GPI anchor 
takes place in the ER lumen. Then the GPI-anchor proteins follow the secretory pathway to be presented at 
the cell surface. Some fungi have an additional step in which the GPI anchor is cleaved after the glucosamine 
and the protein with the remnant part of the anchor is directed to the cell wall and covalently linked to ß-1,6-
glucan (Richard and Plaine, 2007) 
 
Many GPI-anchored proteins of C. albicans have been implicated in virulence, 
as their localization at the cell surface is involved in the interaction with the host cells. 
GPI-anchor proteins are also important for processes like adhesion to mammalian cells, 
phenotypic switching, biofilm formation, CW biosynthesis, interaction with the host 
immune system and stress tolerance (Mao et al., 2008).  
 The number of predicted GPI-proteins in C. albicans is 115 (Richard and 
Plaine, 2007). Most of them have unknown functions (corresponds to 76 genes or 66% of 
the GPI genes).  Many of them are involved in the cell wall biosynthesis or remodelling 
(Phr1, Phr2, Utr2) (15 genes or 13% of the GPI genes) and adherence or host- 
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interactions (Hwp1, Als proteins) (13 genes or 11%). Some have enzymatic functions 
(Sap9, Sap10, Gpi7) and a role in oxidative stress (Superoxide dismutase) (11genes or 
9,5% of the GPI gens) (Richard and Plaine, 2007).   
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I. 3. Immune response to fungal pathogens 
The mammalian immune system consists of two branches: the innate and the 
adaptive immunity. The innate immunity is the major component in response to invading 
pathogens, because it provides the first response in the recognition as well as elimination 
of pathogens. The components of innate immune system include physical and chemical 
barriers, such as epithelia and antimicrobial substances, cells responsible for 
phagocytosis so called phagocytes or phagocytic cells (neutrophils, macrophages, 
granulocytes), mast cells, natural killer (NK) cells, members of the complement system 
and signalling proteins known as cytokines that regulate and coordinate the activities of 
immune cells. The functions of the innate immune system are recruiting of immune cells to 
the side of infection, the production of cytokines, identification and removal of foreign 
substances and activation of the complement system and instructions for the adaptive 
immune system. The innate immune system can in many instances eliminate or kill 
invading pathogens and it is also responsible for the future stimulation of the adaptive 
immune system which has a high specificity for distinct molecules and the ability to 
memorize and respond more powerfully to repetitive infections (Janeway and Medzhitov, 
2002)  
 
Fig.I.3. The main populations involved in the recognition of C. albicans during the innate immune response are 
the monocytes, neutrophils and macrophages. Dendritic cells are crucial for processing of, and antigen 
presentation to, T cells, and thus to activate the more specific adaptive immunity (Netea et al., 2008)  
 
The innate immune response is mediated by professional phagocytes such as 
macrophages, dendritic cells and neutrophils (Mansour and Levitz, 2002) (see Fig.I.3). 
Phagocytic cells are able to recognize structures characteristic for microbial pathogens 
12 
 
and not present in mammals, so called pathogen-associated molecular patterns (PAMPs). 
These cells are able to recognize PAMPs via a small number of germline-encoded 
pattern-recognition receptors (PRRs) on their surface. These innate immune receptors are 
evolutionary highly conserved (Akira and Takeda, 2004b), non-clonal receptors, which are 
constitutively expresses in the host on innate immune system cells like dendritic cells and 
macrophages (Akira et al., 2006). Different classes of pathogens express different PAMPs 
that are recognized by different PRRs (Akira et al., 2006). 
Toll-like receptors (TLRs) are the main class of PRRs, with as yet 12 
members of the TLR family identified in mammals. Toll-like receptors are known to 
activate immune cells in response to different types of microbial components. TLRs are 
type I integral membrane glycoproteins characterized by the extracellular domains 
containing varying numbers of leucine-rich-repeats (LRR) and characteristic cysteine-rich 
motifs at their extracellular regions and a cytoplasmic signaling domain homologous to 
that in interleukin 1 receptor (TIR domain), which is essential for signalling (Bowie and 
O'Neill, 2000). The expression of TLRs is modulated rapidly in response to pathogens, 
where they induce expression of inflammatory proteins. The genes that are expressed 
through TLR signalling are cytokines and proteins important for microbial killing 
mechanisms, because the signaling pathways activated through TIR domain lead to 
activation of proinflammatory transcriptional factors, like NFĸB (Bowie and O'Neill, 2000). 
TLR2 and TLR4 are the best characterized TLRs, and are described as important 
mediators in innate immunity. Four TLRs have been shown to be important for the 
immune defence against C. albicans (TLR2, TLR4, TLR6 and TLR9) (Netea et al 2002 
Miyazato, 2009)  
After the recognition of pathogens, macrophages become activated, resulting 
in pathogen phagocytosis, and secretion of cytokines leading to inflammation. TLRs use 
the same signalling pathway that is used for proinflammatory cytokine interleukin-1 
receptor (IL-1R) signalling (Akira and Takeda, 2004a). Activation of TLRs with their 
ligands recruits adaptor proteins containing TIR domain, such as MyD88, this leads to 
activation of a signalling pathway downstream and production of inflammatory cytokines.  
Nod-like receptors (NLRs) are localized in the cytosol. They are composed of 
an N-terminus effector caspase-recruitment domain (CARD), which is thought to regulate 
homotypic and heterotypic binding, a nucleotide-binding domain (NBD) and leucine-rich 
repeats (LRR) at the C-terminus. Ligand stimulation leads to recruitment of a receptor 
interacting protein 2 (RIP2), which results in the activation of the inhibitor of NF-κB (IκB) 
kinase complex (Ip et al., 2009).  
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Scavenger receptors are mainly expressed by myeloid cells and play an 
important role in the uptake of apoptotic cells and modified host molecules. They are also 
involved in lipid metabolism and bind low-density lipoproteins (Peiser et al., 2002). 
C-type lectin receptors are responsible for binding to the polysaccharides. C-
type lectin receptors are also found on the surface of professional antigen-presenting cells 
like dendritic cells and Langerhans cells where they do not only serve as antigen 
receptors but also regulate the migration of dendritic cells and their interaction with 
lymphocytes. (Figdor et al., 2002).  
Dectin-1 is a C-type lectin receptor, containing an extracellular C-type lectin 
domain, a short stalk region, a single transmembrane domain and a short intracellular tail 
(Ariizumi et al., 2000). This receptor is mainly expressed on macrophages, DCs and 
neutrophils and is involved in a number of immune responses such as phagocytosis 
(Gantner et al., 2005; Hernanz-Falcon et al., 2009), neutrophil degranulation and 
production of cytokines. The role in ROS signalling remains unclear, because the 
macrophages isolated from dectin-/- mice stimulated with C.albicans show no alterations in 
ROS production (Saijo et al., 2007). Dectin-1 plays an important role in fungal β-glucan 
recognition; receptor recognizes β-1,3 glucans via C-type lectin-like domain (CTLD) (Tsoni 
and Brown, 2008). The other CLR known to recognize fungi are dectin-2, macrophage 
mannose receptor (MR) galectin-3, dendritic cell-specific ICAM3-grabbing nonintegrin 
(DC-SIGN) and mincle (Taylor et al., 2005; Taylor et al., 2007).  
The characteristic feature about Dectin-2 is its specificity for high mannose 
structures and the ability to recognize hyphal forms of C.albicans and of other fungi 
(McGreal et al., 2006). The recognition of hyphal forms results activation of NFĸB, and up-
regulation of TNFα and IL-1ra (Sato et al., 2006).  
Mannose Receptor (MR) is also a C-type lectin receptor, able to recognize 
oligosaccahides, fructose and mannose. Receptor mediates phagocytosis of phatogens 
by macrophages. Elected recognition of highly branched N-linked mannosyl chains by MR 
has been shown (Netea et al., 2006). 
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I. 4. Fungal recognition and the ability to escape  
Both the innate and the adaptive immune systems play an important role in 
immune response to fungal infections. Several of fungal PAMPs, like β-glucan, located on 
the surface of the cell are recognized by mammalian TLRs (Netea et al., 2004b) and C-
type lectin receptors (especially Dectin-1) (Goodridge et al., 2009) (see also Chapter I.3). 
C. albicans appears in two different morphological forms, yeast and hyphae. In 
the yeast form the cells are round and are separated; in hyphal growth cells bild long 
filaments, where the single cells are separated by septae (Berman and Sudbery, 2002). 
Both forms interact with the host in a different way, thereby initiating diverse immune 
responses. The ability of C. albicans to avoid an immune response and live as a 
commensal may depend on its location in the host and on its morphological state. 
Dendritic cells are able to discriminate between yeast and hyphal forms of C. albicans, 
and the uptake of opsonized cells occurs through different receptors (d'Ostiani et al., 
2000). C. albicans mutants lacking the ability to switch from the yeast to hyphae form are 
avirulent (Lo et al., 1997).  
One of the characteristics, allowing C. albicans to survive within the host is a 
specific difference in the cell wall composition in the yeast and hyphal forms. β- glucan is 
the main component in the cell wall that is recognized by immune cells. The binding of β-
glucan to the Dectin-1 receptor on the macrophages leads to phagocytosis of the 
pathogen (Brown et al., 2002). However, only the yeast form of C. albicans triggers 
Dectin-1 immune response whereas filaments do not (Underhill et al., 2005). This fact can 
be explained by the down-modulation of β-1,6 glucan expression during yeast-to-hyphae  
transition. In hyphal form, the filamentous daughter cells also do not separate from each 
other and the β-glucan layer remains concealed and covered with mannan. Therefore β -
glucan masking is another strategy of C. albicans to escape the host immune system and 
explains why filaments are more virulent (Chai et al., 2009). 
The loss of TLR-4 mediated proinflammatory signals is the mechanism of 
Aspergillus to escape host immune defence (Netea et al., 2003). It has been also 
demonstrated that C. albicans is using the same mechanism as Aspergillus species to 
suppress the host immune system. TLR4-mediated proinflammatory signals are lost 
during transition of Candida into hyphae (van der Graaf et al., 2005). TLR2 and TLR4 both 
recognize C. albicans, but only TLR2 is able to recognize hyphal forms. The recognition of 
C. albicans by TLR2 induces an anti-inflammatory cytokine production. Phenotypic 
switching from yeast to hyphae leads to release of IL-10 and induces immune suppression 
(Netea et al., 2004a; Netea et al., 2004b). C. albicans recognition by TLR2 inducing anti-
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inflammatory response helps C. albicans to escape host immune defence. Hyphal forms 
are less stimulatory for cytokine production in human monocytes than yeast forms 
(Torosantucci et al., 2000). 
 
As already mentioned, about 50-60% of the C. albicans cell wall are β-glucans. 
β-glucans are localized below the mannose layer but is also presented on the surface via  
bud scars (Gantner et al., 2005). They are recognized by following receptors: CR3 and 
dectin1. Carbohydrate recognition by CR3 is mediated by a lectin domain and is specific 
for hyphal and yeast forms of C. albicans. Dectin-1 is a major receptor on macrophages 
for the phagocytosis of different fungi. It has been shown, that Dectin-1 is able to interact 
with other receptors to induce a strong inflammatory response (Gantner et al., 2003), but 
Dectin-1 is not recognizing the filamentous forms of C. albicans.  
Chitin is also recognized as a fungal PAMP. The recognition leads to a 
immune response and release of IL-4 and IL-13. Although, the receptors for chitin 
recognition have not been described so far.  According to their localisation, mannoproteins 
and mannans on the outer side of the cell wall may be the first components that come into 
contact with immune cells. There is a number of receptors on the immune cells involved in 
recognition of mannans and mannoproteins of C. albicans. The main receptor on 
macrophages assigned for mannan recognition is the C-type-lectin mannose receptor, 
recognizing branched N-bound mannans in C. albicans; the recognition of shorter O-
bound mannan occurs by TLR4 (Netea et al., 2006). Mannose and mannoproteins can be 
also recognized by Dectin2, which is a receptor on the surface of myeloid cells and 
inflammatory monocytes and has the ability to recognize hyphal forms of C.albicans 
additionally to yeast forms (McGreal et al., 2006). However, glycolsylation is an important 
factor for the recognition and phagocytosis of C.albicans by macrophages.  The 
phagocytosis by the mutans deficient in phasphomannan biosynthesis is significantly 
reduced (McKenzie et al.). 
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I. 5. Phagocytosis 
A phagocyte has many specific receptors on its surface that bind peptides, proteins and 
microbial cells. They include receptors for opsonin, mannose and scavenger receptors, 
toll-like receptors and different G-protein coupled receptors. All those receptors have the 
task either to recognize pathogens or to promote phagocytosis and kill ingested microbes. 
It has been shown, that dectin-1 is directly involved in the uptake of fungal pathogen 
(Ezekowitz, 1990; Romani et al., 2004), while mannose receptors are not professional 
phagocytic receptors, TLRs may be involved in detecting, but not in the uptake of 
pathogens (Blander and Medzhitov, 2006). Receptors for phagocytosis (FcR) have a 
tyrosine-based activation motive (ITAM). Phosphorylation on tyrosine residues occurs on 
the ITAM consensus sequences and leads to recruitment and phophorylation by Syk 
kinase (Greenberg et al., 1996). Syk kinase plays an important role in the phagocytic 
signal transmission (Zhang et al., 1996; Cox et al., 1996). 
After phagocytosis, killing of C. albicans occurs through oxidative and non-
oxidative mechanisms. The oxidative mechanism is also known as the oxidative or 
respiratory burst and is throught to require dectin-1. Activated macrophages and 
neutrophils convert molecular oxygen to reactive oxygen species (ROS), which is used to  
destroy microbes. ROS production occurs after assembly and activation of nicotinamide 
adenine dinucleotide phosphate (NADPH) oxidase on the cell surface. NADPH oxidase is 
an enzyme that catalyses the production of superoxide (O2-) from oxygen and NADPH: 
NADPH + 2O2 NADP+ + H+ + 2O2-  (Babior, 2004). Other oxidizing agent produced by 
NADPH oxidase is hydrogen peroxide H2O2 generated by dismutation of superoxide. In 
neutrophils, H2O2 is used by the enzyme myeloperoxidase to catalyse hypohalous acids 
from halide ions (Cl-, Br-,I-). Hypohalous acids are highly toxic for bacteria.  
In addition to ROS, macrophages produce reactive nitrogen intermediats 
(RNS). During the conversion of arginine to citrulline, which is catalyzed by iNOS, nitric 
oxide gas is released. Further, peroxynitrite radicals are generated through the interaction 
between ROS and NOS, which kill pathogens inside the phagosome (Fig.I.4.) These 
reactions are also known as respiratory burst (Schrenzel et al., 1998). However, hydroxy 
and superoxide radicals are also very reactive to the host cell, since they react with 
cellular components, resulting in the oxidation of proteins and nucleic acids, that may lead 
to inactivation of enzymes, mutations in DNA and proteins and cell death. Nevertheless, 
the respiratory burst is an important antifungal defence mechanism.  
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Fig.I.4. Phagocytosis and destruction of microbes. Pathogens are ingested by different membrane 
receptors on phagocytes. The pathogens are then taken up and fused with lysosomes. In this phagolysosome 
the microbes are killed by ROS and iNOS (Abul K. Abbas, 2005). 
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I. 6. Superoxide dismutases in C. albicans 
 
Free radicals that are produced in the phagosome during an immune response 
are usually also produced in small amounts during redox reactions in somatic cells. Since 
free radicals are very reactive and damage to DNA and proteins, cells have developed 
several mechanisms to minimize the amount of free radicals. There are enzymes called 
superoxide dismutase, catalase and glutathione peroxidase responsible for neutralizing 
these free radicals.  
Once inside the phagosome, C. albicans has developed strategies to use 
enzymes for ROS detoxification. This provides C. albicans a possibility to escape killing 
the host immune system.  
The Cat1 catalase in C. albicans is implicated in counteracting the respiratory 
burst and protects cells from killing (Chauhan et al., 2006). The important role of another 
enzyme, superoxide dismutase Sod5, in detoxifying ROS and protection of C. albicans 
has also been shown (Frohner et al., 2009). Mutants lacking Sod5 have defects in 
virulence (Martchenko et al., 2004), and decreased viability in coculture with macrophages 
compared when to the wild type (Frohner et al., 2009). SODs convert superoxide radicals 
into hydrogen peroxide, which is less damaging to the cell. All SODs are depending on 
metal co-factors such as Cu/Zn, Fe or Mn. The classifications of SOD enzymes into 
families is according to co-factors. There are two types of superoxide dismutases in 
eukaryotic cells: cytosolic copper- and zinc- dependent and mitochondrial manganese- 
dependent SODs (Fridovich, 1995).  
SODs protect the cells from the superoxide toxicity and are very important 
antioxidants in the cell, as shown by knock-out approaches in the mice. Mice with a knock 
out have a reduced life span and several pathologies (Elchuri et al., 2005). Mice lacking 
Sod2 die several days after birth from the massive oxidative stress (Lebovitz et al., 1996;  
Li et al., 1995). SOD knock-outs have been performed in other model organisms as well. 
In prokaryoties, the loss of SODs leads to attenuated virulence.  
Six different SOD genes have been identified in C.albicans. C. albicans Sod2 
and Sod3 need manganese as a cofactor. Sod2 is localized in the mitochondria, Sod3 is a 
cytoplasmic enzyme. Sod1, Sod4, Sod5 and Sod6 are CuZn dependent enzymes. Sod4, 
Sod5 and Sod6 are predicted to be localized in the cell wall and to be GPI-anchored 
proteins (Fradin et al., 2005; Richard and Plaine, 2007). 
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Sod5 is one of the most studied SODs in C. albicans. Sod5 is characterised as 
an important virulence factor. C.albicans strains lacking SOD5 show attenuated virulence 
in mice in vivo (Martchenko et al., 2004) and reduced survival in co-culture with 
macrophages (Frohner et al., 2009). SOD5 is expressed during yeast-to-hypha 
transitions, also during oxidative or osmotic stress and increased pH (Martchenko et al., 
2004) and SOD5 is also upregulated during phagocytosis (Fradin et al., 2005).  
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I. 7 Aims of my diploma thesis 
 
Sod5 is one of six superoxide dismutases in C. albicans. Sod5 is a copper-zinc 
dependent enzyme involved in detoxification of extracellular superoxides produced by 
macrophages and neutrophils. Cells lacking SOD5 have attenuated virulence and reduced 
survival in coculture with macrophages (Frohner et al., 2009).  We were interested to 
identify the exact cellular localization of this protein. Therefore, we wanted to visualize this 
protein as a GFP- fusion protein Sod5-GFP. This method enables us to study the 
localization of this protein under the microscope and on Western blot using anti-GFP 
antibody.  
 
The main aim of my thesis was the further characterisation of the protein.  
 
Therefore I had to:  
 
 
1. To create C. albicans strains expressing XFPs under constitutive expressed 
and SOD promoters and to study promoter activity of Sod5. As previous 
publications show, SOD5 promoter is induced under yeast-to-hyphae 
transition and under osmotic stress. I tried to confirm this using constructs 
with GFP tagged SOD5 promoter.  
 
2. To study the localisation of Sod5 using a strain with GFP-tagged Sod5. 
Therefore, I had to clone the construct and to test Sod5-GFP for functionality 
and to detect the localisation using a fluorescent microscope.  
 
3. Another part of my diploma thesis was to produce and characterise specific 
polyclonal antibodies against Sod4, Sod5 and Sod6 proteins.  
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II. Materials and Methods 
 
II. 1. C. albicans Methods 
 
1. Media for C. albicans 
 
1xYPD  20g/l  Bacto Peptone (BD Biosciences) 
10g/l  Yeast extract (BD Biosciences) 
2% Glucose (w/v) (Merck) 
 
Yeast extract and bacto peptone are dissolved in 900ml ddH2O and autoclaved separately 
for 20min at 121°C. A 20% glucose solution is autoclaved separately and added at final 
concentration of 2% to 900 ml sterile YP-medium.  
 
2xYPD  40g/l  Bacto Peptone (BD Biosciences) 
  20g/l  Yeast extract (BD Biosciences) 
  4%  Glucose (w/v) (Merck) 
 
For YPD plates: Yeast extract and peptone are dissolved in 200ml H2O and autoclaved 
for 20min at 121°C. 50ml of 20% glucose solution are added to YP-media as well as 
250ml 4% autoclaved bacteriological agar (w/v) (BD Biosciences).  
 
Minimal medium:  
16,75 g/l Bacto YNB (w/o AA and (NH4)2SO4) (BD Biosciences) 
  12,5 g/l Ammoniumsulfat (Merck) 
 
Glucose is added to 200ml minimal medium at a final concentration of 2%. For plates 
250ml of 4% bacteriological agar are added to the medium (final concentration 2%).  
 
2xSC:  4,5 g/l Bacto YNB w/o AA and (NH4)2SO4 
  3,9 g/l Amino acid Mix (all aminoacids from Sigma) 
  10 g/l Ammoniumsulfat       
  
Bacto-YNB, (NH4)2SO4 and amino acid mix are dissolved in 740ml H2O and autoclaved 
at 121°C for 20min. pH is controlled before autoclaving and regulated to pH5,5 – 6. 
For liquid medium: 185ml 2xSC, 50ml 20% glucose stock solution, 250ml H2O, and 5ml of 
the required amino acids from the 100x stock.  
For plates: use instead of H2O 250ml of autoclaved 4% bacteriological agar (w/v).  
 
For stock solutions: 
 
100x URA :   0,4g of L-uracil in 100ml H2O 
100x HIS:   0,6g of L-histidine in 100ml H2O 
100x LEU:  2,6g of L-leucine in 100ml H2O 
 
This 3 stocks can be autoclaved at 121°C for 20min. 
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100x Trp:   0,8g of L-tryptophane in 100ml H2O  
 
Tryptophane stock has to be sterilfiltered (Millipore 0,22µm filter) and stored in the dark at 
4°C. 
 
Amino acids mix (Sigma):  
   g per 11.7 g mix  
     
Adenine 
L-arginine 
L-tyrosine 
L-isoleucine 
L-phenylalanine 
L-glutamic acid 
L-aspartic acid 
L-threonine 
L-serine 
L-valine 
L-methionine 
0,4 
0,2 
0,3 
0,3 
0,5 
1,0 
1,0 
2,0 
4,0 
1,5 
0,5 
 
Growth of Candida species 
 
 C. albicans strains are grown to saturation overnight in YPD with continuous 
shaking at 30°C. 
 Next morning, the cultures are diluted to 0.2 OD600 in 25ml YPD and incubate with 
continuous shaking at 30°C until the culture reaches an OD600 ~1. 
 
 
2. Colony-PCR 
 
Single yeast colony can be used for a PCR reaction instead of isolated DNA. Pick and 
dissolve some cells from one colony in PCR-mix 1 or H2O using a sterile tooth pick. Break 
the cells by heating in the PCR machine for 10min.  
 
Colony PCR-Mix1: 1X 
 
30 μl      H2O (+cells) 
4 μl        dNTPs    [25mM] 
3 μl        Primer 1 [10µM] 
3 μl        Primer 2 [10µM] 
 breack up the cells by heating  
at 93°C for 10 min 
 put reaction on ice 
 
Colony PCR Mix-2: 1x 
5 μl       10x Taq Buffer 
4 μl        H2O  
1 μl       Taq Polymerase 
 
 add Mix 2 to the reaction 
PCR-Programm: 
I: preheating       94°C  pause 
II: 10min             94°C  PCR on ice+ 
Master-Mix2 
III: 5min              94°C  
IV: 30 sec           94°C 
      30 sec          50°C          x 30-35 
      xxmin           72°C  
III: 10 min           72°C 
IV: hold              10°C 
Annealing temperature depends on the 
primer 
Elongation time is depending on the size of 
the amplified fragment.  
23 
 
 
 
3. Extraction of C. albicans chromosomal DNA 
 
 Grow an overnight culture in 10 ml YPD Medium at 30°C 
 Harvest the cells at 2500rpm, 5minin a microfuge 
 Resuspend the pellet in 500μl H2O and pipette cell suspension into screw-cap 
tube. 
 Centrifuge again for 5min, at 2500rpm 
 Resuspend cells in 200μl DNA lysis buffer by vortex-mixing, add 1 volume glass 
beads and 200μl PCI (phenol/chloroform/isoamyl alcohol) 
 Put tubes on Vibrax to break up cells by full speed at 4°C for 60min. 
 Add 200μl sterile water to the cell suspension. 
 Spin down for 5min, 14000rpm 
 Transfer aqueous toplayer into new tube, add 1ml ice-cold 100% ethanol. 
 Incubate on -20°C for 30min. (or overnight) 
 Centrifuge for 15min, 14000rpm. 
 Resuspend pellet in 400 μl 1xTE +3µl RNAse A and incubate at 50°C for 50min. 
 Repeat PCI step 
 Transfer the supernatant into a new tube, add 10µl 3M NaAc and 1ml ice-cold 
EtOH  
  Incubate on -20°C for 30min (or overnight) 
 Centrifuge 15min, 14000rpm 
 Wash the pellet in 70% ethanol and let it dry at 55°C 
 Resuspend the pellet in 30-50μl H2O or TE 
 
Lysis buffer: 
2% Triton X-100 (Sigma) 
1% SDS (Applichem) 
10mM  Tris/Hcl pH8,0 (Amresco) 
1mM  EDTA (Sigma) 
 
 
 
4. Yeast electroporation 
 
Competent yeast cells: 
 Grow the culture in YPD overnight, and dilute to an OD600= 0.2 in the morning, and 
regrow to the logarithmic growth phase until OD600 ~ 1. 
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 Alternatively dilute the culture 1x105 in 50ml YPD and grow on 30°C overnight 
OD600 ~1,5 
 Transfer culture into 50ml Falcon tubes. 
 Harvest cells by centrifugation 5min, 3000rpm. 
 Resuspend cells in 8ml H2O by vortex-mixing.  
 Add 1ml 10xTE and 1ml 1 M LiAc 
 Incubate by shaking at 150rpm, 30°C, 60min 
 Add 250μl DTT. Incubate and shake slowly (30°C, 30min, 150rpm) 
 No vortex-mixing from now on 
 Add 40ml H2O 
 Harvest the cells by centrifugation (4°C, 5min, 3000rpm) and keep cells on ice 
from now on! 
 Resuspend cells gently in 25ml cold H2O and centrifuge (4°C, 5min, 3000rpm) 
 Resuspend cells gently in 5ml cold 1 M Sorbitol and centrifuge (4°C, 5min, 
3000rpm) 
 Resuspend cells gently in 550μl cold 1 M Sorbitol 
 
Transformation by electroporation: 
 Put 43μl cell solution and 7μl of DNA construct into a clean electroporation cuvette 
 Electroporator settings: BioRad gene pulser 200Ω, 1,5kV, 25µF; time constant 
~4,6 
 Add 950μl YPD and transfer into a 1,5ml tube. 
 Incubate and shake slowly (30°C, 4h) 
 Plate on selection plates 
 Incubate at 30°C for 1-2 days 
 
4. Indirect immunofluorescence of C. albicans 
 
 Grow overnight culture and dilute it next morning 1:100 and grow to OD600 ~1 
 Prepare a 24 well-plate with 12mm round glass slides and coat slides by spotting 
200µl of Concanavalin A solution (6mg/ml) on them and incubating for 45min. 
 After incubation aspirate the liquid, wash one time with water and air dry slides. 
 Add 200µl of a 2x106 fungal cell suspension (=4x105 cells/well) into each well and 
let cells settle on the coated glass slides for 30min. 
 Aspirate unbound cells carefully from the edge of the wells. 
 Wash gently with 0,5ml sterile PBS two times. 
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 Fix fungal cells with 300µl of 5% buffered parafomaldehyde for 15min on room 
temperature (RT). Discard paraformaldehyde solution and wash 3 times with 
sterile PBS. 
 Incubate cells in blocking buffer (4% BSA/PBS) for 1h at RT. 
 Aspirate blocking buffer and replace with 300µl of primary antibody or dilution 
(1:100 to 1:1000) in blocking solution. Incubate overnight at 4°C. 
 The next morning wash 5 times with ice-cold sterile PBS. 
 Add 300µl of secondary antibody dilution (1:700; anti-rabbit Cy5-conjugate) in 
blocking solution and incubate for 2h at RT in the dark. 
 Wash 5 times with ice-cold sterile PBS. 
 Carefully invert the cover slips onto a drop of mounting medium for fluorescence 
on a microscopy slide. Observe slides under the microscope using contrast phase 
and Cy5 (ex 650nm/em 670nm) filters. 
 
6. Filipin staining of yeast plasma membrane 
 
Filipin is dissolved in DMSO at a concentration of 5mg/ml and stocks are stored in 
20µl aliquots. Filipin fluorescence is not stable, it bleaches quickly  
 
Prepare a working solution always fresh and use for staining immediately: 20µl of 
filipin stock in 10ml PBS (1:500 dilution). For using filipin plus the antibody, you can 
add filipin (1:100 dilution) in blocking buffer (10% FBS) after incubation with secondary 
the antibody and incubate for 30 min at 37°C.   
 
 Rinse cells 3x with PBS 
 Stain cells with working solution for 30 min at RT 
 Wash cells 3x with PBS 
Use mounting media for slide preparation 
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II. 2. Bacteriological Methods 
 
 
1. Media for E.coli  
  
1xLB     10g/l  Tryptone (Merck)  
5g/l  Yeast extract (DIFCO)  
10g/l  NaCl (Sigma) 
 
2xLB     20g/l  Tryptone (Merck)  
10g/l  Yeast extract (DIFCO)  
20g/l  NaCl (Sigma) 
 
Yeast extract, tryptone and NaCl are dissolved in 1000ml ddH2O and autoclaved for 
20min at 121°C. pH is controlled before autoclaving and regulated to pH 7 – 7,5.  
For LB plates 250 ml 4% autoclaved bacteriological agar (w/v) is added to 250 ml 
autoclaved 2xLB. For LB+AMP medium or plates, ampicillin is added at a final 
concentration of 0,1 mg/ml. Medium and plates containing ampicillin are stored at 4°C. 
 
2. Preparation of competent E.coli 
 
 Grow E.coli (DH5α) overnight culture in 500ml SOB medium at 18°C or RT to 
OD600 ~1 
 Chill bacterial culture on ice for 20min 
 Spin down at 2500rpm and 4°C for 10min (split up in sterile 50ml falcons) 
 Resuspend the pellet in 15ml ice-cold TB by swirling the centrifuge breaker gently 
and put on ice for 10min 
 Spin down at 2500rpm and 4°C for 10min 
 Resuspend in 35ml ice cold TB (gently) 
 Add DMSO (tissue culture grade) to a final concentration of 7% (v/v) and put on 
ice for 10 min 
 Make 500µl aliquot, shock-freeze them in liquid nitrogen and store at -80°C 
SOB medium: 
2%           Tryptone (w/v) (BD Biosciences) 
0,5%        Yeast extract (BD Biosciences) 
10mM      NaCl (Sigma) 
2,5mM     KCl (Sigma) 
20mM      MgCl2 (Sigma) 
 
Dissolve tryptone, yeast extract and NaCl in H2O, add KCl, pH to 7,5 with 5M NaOH, 
adjust to final volume, autoclave and add sterile MgCl2 
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TB: 
10mM      Pipes 
55mM      MnCl2 
15mM      CaCl2 
250mM    KCl 
 
Mix all components except MnCl2 in H2O, adjust to pH 6,7 with KOH, add MnCl2, adjust to 
final volume and sterilise by filtration through a 0,45µm filter, store at 4°C.  
 
3. Transformation of competent bacteria 
 
 Thaw competent cells on ice 
 Gently mix the cells and aliquot 100-200µl competent cells to each DNA sample 
(0,5- 1µg)  
 Incubate cells on ice for 30min 
 Heat-shock cells for 45sec at 42°C 
 Place them on ice for 2min 
 Add S.O.C. medium and shake at 300rpm at 37°C for 1h.  
 
II.3. DNA Methods 
 
 
1. Agarose gel electrophoresis  
 DNA samples (5-50 μl) are mixed with an appropriate amount of 10x loading buffer  
 Load samples on a gel containing 0,7-1,5% agarose in TAE buffer and 0.5 μg/ml 
ethidium bromide, in electrophoresis chamber filled with electrophoresis buffer  
 Load 5 μl molecular weight standard on the gel (Bioline Hyperladder I)  
 Separate DNA fragments in an electric field with 80-100 Volts  
 Visualize nucleic acid fragments under UV-light and compare fragment size to 
molecular weight standards  
 
TAE (50x stock solution):  
2 M  Tris-HCl pH8  
1 M  Acetic acid  
50 mM  EDTA  
 
Electrophoresis buffer:  
1x TAE  
 
Loading buffer:  
1,2 ml      10xTAE  
0,6 ml       5% Bromphenol blue  
0,6 ml        5% Xylene cyanol  
4,8 ml      100% Glycerol  
4,8 ml       H2O  
0,45 μm filter-sterilize  
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2. Polymerase-chain-reaction (PCR) 
 
PCR-Mix (50µl): 1X 
 
5µl        10xPCR buffer 
5µl        dNTP’s [25mM] 
2 µl        fwd-primer [10µM] 
2 µl       rev-primer [10µM] 
1µl        DNA (20-100ng) 
0,5µl     Polymerase Taq [5U/µl] 
34,5µl   H2O 
 
PCR-Programm: 
I: 5 min         94°C 
II: 30 sec      94°C 
    30 sec      50°C          x 30-35 
    xxmin       72°C  
III: 10 min     72°C 
IV: pause     10°C 
Annealing temperature depends on the 
primer melting temperature 
Elongation time is depending on the size of 
the amplified fragment 
 
 
 
3. Plasmid mini preparation 
 
 Spin down 2x2ml of an overnight culture at 6000rpm for 2min 
 Resuspend the pellet in 500µl STET buffer and put on ice 
 Add 20µl of Lysozyme (20mg/ml), mix by inverting several times and incubate on 
ice for 5 min 
 For lysis incubate suspention at 95°C for 70 min, put on ice afterwards 
 Centrifuge at 14000rpm for 10min 
 Remove the pellet from the eppendorf tube using sterile tooth pick 
 Precipitate by adding 500µl isopropanol and mixing several times at room 
temperature for 15min 
 Spin down at 14000rpm at 4°C for 10min 
 Wash pellets with 70% EtOH, and centrifuge at 14000rpm for 5 to 10min 
 Dry pellet and resuspend in 100µl TE or water  
 Add RNaseA to final concentration of 50µl/ml 
 
1xTE: 
 
10mM  Tris (Amresco) 
1mM  EDTA (Sigma) 
The pH should be adjusted to pH 8,0 with HCl. 
 
STET-buffer (100ml): 
 
8%  Sucrose (Merck) 
10%  Triton X-100 (Sigma) 
50mM  EDTA (Sigma)  
50mM   Tris/HCl pH 8,0 (Amresco) 
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4. QIAGEN Plasmid midi protocol 
 
 Grow E.coli cells containing the desired plasmid in 50ml LB+Antibiotic at 37°C 
overnight 
 Harvest cells by centrifugation at 6000xg for 15min at 4°C in the centrifuge 
 Resuspend cell pellet in 4ml Buffer P1 (QIAGEN) 
 Add 4ml of Buffer P2 (QIAGEN), mix gently by inverting several times and 
incubate at RT for 5min. 
 Add 4ml of chilled Buffer P3 (QIAGEN), mix thoroughly by inverting several times 
and incubate 15 min on ice. 
 Centrifuge at 20000xg for 30min at 4°C and re-centrifuge supernatant again for 
15min. 
 Equilibrate a QIAGEN-tip 100 by applying 4ml Buffer QTB (QIAGEN) and allow the 
column to empty by gravity flow. 
 Apply the supernatant from the step before to the QIAGEN-tip and allow it to enter 
into the resin by gravity flow.  
 Wash the tip twice with 10ml Buffer QC (QIAGEN) 
 Elute DNA with 5ml Buffer QF (QIAGEN) 
 Precipitate DNA by adding 3,5ml isopropanol at RT 
 Mix and centrifuge immediately at 15000x g for 30min at 4°C 
 Decant supernatant and wash pellet with 2ml 70% ethanol. Centrifuge again at 
15000x g for 10min at 4°C. 
 Decant supernatant, air-dry the pellet for 15mon and redissolve DNA in 100µl 
sterile H2O.  
 
 
 
5. Cloning procedures  
 
Plasmid digestion 
 
Use a small digestion-mix for a control digest or big mix for digest during cloning.  
 
Small Mix (30μl)  for control digestion: 
 
2 μl ( 3-5µg)   DNA-solution 
3 μl   Buffer (10x) 
0,5μl   Restriction enzyme (10U/µl, end concentration 1U/1µg) 
24,5μl   H2O 
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Incubate for 2h at 37°C  
 
 
Big Mix (100µl)  for preparative digestion:  
 
10-20µl (30µg)   DNA  
10µl    Buffer (10x) 
2-3µl   Restriction enzyme (10U/µl, end concentration 1U/1µg) 
x µl   H2O 
 
Incubate for 3-4h or overnight 
 
Phosphatase treatment  
 
 After restriction digest, add 1 μl alkaline phosphatase (1U/μl) (Roche) to the 
reaction mix.  
 Incubate 45 min at 37°C.  
 DNA can be precipitated with ethanol.  
 
Ligation 
 
Ligation-mix: 
 
5µl  2x ligation buffer  
2µl  pGEM-T vector (1:5 dilution) 
X µl  PCR product 
1µl  T4 DNA ligase 
X µl  H2O  
10µl 
Ligation of DNA fragments  
Ligation was carried out with T4-Ligase Fermentas , using vector and insert at a molar 
ration of 1:3.  
 
 
 
Incubate ligation mix for 3-4h at RT or overnight at 4°C before transforming 5-10µl into 
competent E.coli cells. 
 
 
6. Gel elution (Peq Lab) 
 
 Excise the DNA fragment from the agarose gel with a clean, sharp scalpel. 
 Add the same volume of Buffer XP2 
 Incubate at 55-65°C for 10 min (or until the slice has completely dissolved). Check 
that the colour of the mixture is yellow (pH > 7,5) otherwise add 5M sodium 
acetate till the colour turns into yellow (5-10µl).  
31 
 
 Place a HiBind spin column in a provided 2ml collection tube and apply the sample 
(max. 750µl) to the column and centrifuge for 1min, at 10.000rpm 
 Discard flow-through and place HiBind column back into the same collection tube. 
Load the sample again if necessary.  
 Wash 2 times with  600µl SPW- Buffer, centrifuge (1min, 10.000rpm) 
 Discard flow-through. Place the column back into the same tube. Centrifuge for 
 Additional 1min to dry the column.  
 Place HiBind column in a clean 1,5ml Eppendorf tube 
 Elute DNA with 30-50μl elution buffer or H2O and centrifuge column for 1min, 
5000rpm 
 
 
7. DNA precipitation 
 
 Add 2,5 volumes of EtOH/ 0,1 volume NaAc 
 Mix by inverting several times 
 Put on -20°C for 20 min or overnight 
 Centrifuge (10min, 14.000rpm) 
 Wash pellet with 70% EtOH 
 Centrifuge again (10min, 14.000rpm) 
 Dry pellet (heating block) 
 Resuspend in 30-50μl H2O 
 
 
8. Southern blotting with DIG High Prime 
 
Agarose gel for electrophoresis of genomic DNA: 
 
 Pour a big (500ml) gel containing 0,7% agarose in 1x TBE 
 Load genomic DNA samples (precipitated to a volume of 20µl) on the gel and put 
in electrophoresis chamber filled with 1x TBE 
 Load 5µl molecular weight standard  (Bioline Hyperladder I) on the gel 
 Apply an electric field of 60-80 volts to separate the genomic DNA 
 Mark bands of molecular weight standard on the agarose gel with a sterile scalpel 
 
Denaturation and neutralization of the agarose gel: 
 
 Wash agarose gel for 1h in 0,5M NAOH, 1,5M NaCl 
 Wash agarose gel for 1h in 0,5M Tris/HCl pH 7,5, 1,5M NaCl 
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Capillary Blotting: 
 
 Prepare blotting stock in a glass tray as follows: 
2 pieces of Whatman-paper soaked in 20x SSC 
Agarose gel (upside down)  
Nylone membrane soaked in 20x SSC 
Put pieces of Parafilm at the sides to seal the blot  
1 piece of dry Whatman-paper  
Stack of green towels 
Put a 1kg weight on top 
 Blot overnight 
 Mark bands of molecular weight marker on the membrane with a pencil 
 Cross-link DNA on the membrane using Stragene UV Crosslinker  
 
Labeling of DNA: 
 
 Dilute 1µg template DNA in double distillated water to final volume of 16µl.  
 Denature the DNA by heating for 10min and quickly chilling in an ice 
 Mix DIG-High Prime thoroughly and add to the denatured DNA, mix and centrifuge 
briefly. Incubate for 1h or overnight at 37° C.  
 Stop the reaction by adding 2µl 0,2M EDTA and/or by heating to 65°C for 10 min.  
 
Prehybridisation: 
 
 Pre-heat an appropriate volume of DIG Easy Hyb (4°C  Kühlschrank bottle 7) to 
hybridization temperature of 37-42°C  
 Prehybridize filter for 30 min with gentle agitation in an appropriate container.  
 Denature DIG-labeled DNA probe by boiling for 5 min and rapidly cooling in ice. 
 Add denatured DIG-labeled DNA probe to the pre-heated DIG Easy Hyb and mix 
well (avoid foaming)  
 Pour off prehybridisation solution and add probe mixture to membrane.  
 Incubate 4h- overnight with gentle agitation, 42°C. 
 
Stringency washes: 
 
 Wash 2x 5min in ample 2x SSC, 0,1% SDS at 15-25° C under constant agitation. 
 Wash 2x 15min in 0,5x SSC, 0,1% SDS (prewarmed to wash temperature) at 65-
68° C under constant agitation.  
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Detection:  
 
 After hybridization and stringency washes, rince membrane 1-5 min in Washing 
Buffer  RT 
 Incubate for 30min in 10ml Blocking solution. 
 Incubate for 30 min in 10ml Antibody solution. 
 Wash 2x 15min in 100ml Washing buffer.  
 Equilibrate 2-5 min in 20 ml Detection buffer.  
 Place membrane with DNA side facing up on a development folder and apply 1ml 
CSPD ready-to-use (bottle 5). Immediately cover the membrane with the second 
sheet of a folder to spread the substrate evenly, avoid airbubbles, and incubate for 
5min at 20-25 ° C. 
 Squeeze out excess liquid and seal the edges of the development folder.  
 Incubate the damp membrane for 10min at 37°C to enhance the luminescent 
reaction.  
 Exposure to a appropriate imager for 15-20 min or to X-ray film for 15-25 min at 
15-25°C.  
 
Solutions: 
Blocking Solution:  Blocking solution (bottle 6) diluted 1:10 in maleic acid buffer 
Washing buffer: 0,1M Maleic acid, 0,15M NaCl; pH 7,5; 0,3% Tween 20 
Maleic acid buffer: 0,1M Maleic acid, 0,15M NaCl, adjust with NaOH to pH 7,5 
Detection buffer: 0,1M Tris-HCl, 0,1M NaCl, pH 9,5 
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II. 4. Protein Methods 
 
1. SDS-polyacrylamide gel electrophoresis (SDS-PAGE)  
 
Samples were mixed with 2xsample buffer and loaded on the gel. The gels were run at 
180V until the bromphenol blue front reached the gel bottom. 
7.5% running gel:   
    
5 ml       H
2
O      
2,5 ml     1.5 M Tris pH 8.8    
2,5 ml     Acrylamide (30%)    
50 μl       SDS (20%)      
10 μl        TEMED      
100 μl      APS (10%)  
     
Add TEMED and APS at the end and pour the solution immediately between the glass 
plates. Allow the gel to polymerize. Then the stacking gel solution can be prepared and 
poured and the comb has to be plased to create the wells.  
 
10% running gel:  
   
4,2ml        H2O    
2,5ml     1.5 M Tris pH 8.8   
3,3 ml  Acrylamide (30%)  
50           SDS (20%)   
10µl             TEMED  
100           APS (10%)    
       
4.5% stacking gel:  
 
6 ml      H
2
O  
2,5 ml   0.5 M Tris pH 6.8  
1,5 ml   Acrylamide (30%  
50 μl     SDS (20%)  
10 μl     TEMED  
100 μl   APS (10%)  
 
 
Protein sample buffer:      Running buffer (1l):  
 
40mM   Tris/HCl pH6.8       1,5 g  Tris  
8 M   Urea       7,2 g  Glycine  
5%   SDS       4,0 g  SDS  
0,1mM     EDTA  
1%   ß-Mercaptoethanol- freshly added  
0,1 g/l   Bromphenolblue- freshly added  
 
 
2. Coomassie-staining of protein gels  
 
 Stain protein gel by shaking for 30 min in Coomassie-staining solution. 
 Wash gel in destaining solution until background is completely destained. 
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 Dry gel  
 
 
Coomassie staining solution: for 2l  
 
200 ml   Glacial acetic acid  
500 ml   Isopropanol  
0,67 g  Coomassie blue (G250)  
1300 ml  H
2
O  
 
Destaining solution: for 1l  
 
250 ml   Methanol  
70 ml   Glacial acetic acid  
680 ml  H
2
O  
 
3. Semi-dry protein transfer for immunoblotting 
 
 Prepare the blotting sandwich as followed: 
On the bottom (=anode electrode) of the semi-dry transfer cell from Biorad (Trans-
Blot SD) place: 
1. 6 pieces of Whatman-paper (6x9 cm) soaked with anode-buffer 1 
2. 3 pieces of Whatman-paper (6x9 cm) soaked with anode-buffer 2 
3. Nitrocellulose membrane (6x9 cm, Protran; Schleicher & Schuell) 
moisturized with anode-buffer 2 
4. Gel 
5. 9 pieces of Whatman-paper (7,5x10 cm) soaked with cathode-buffer 
 Cover the sandwich with the lid (= cathode electrode) of the blotting machine. 
 Blot for 50min at 25V with Trans-Blot Semidry Transfer Cell from Biorad. 
 Detect the transfer quality by Ponceau staining (Fluka Chemika) of proteins on 
the membrane. 
 Destain the membrane by washing in H2O 
 Block unspecific binding by shaking overnight at 4°C in Blotto (5% milk diluted in 
1x TBS and  0,1% Tween-20)  
 Add the primary antibody diluted in Blotto  
 Incubate for 1h by shaking at room temperature or overnight at 4°C 
 Wash three times for 15 min with TBS-T (1xTBS, 0,1% Tween-20)  
 Add the secondary antibody diluted in TBS-T, incubate for 1h at RT 
 Wash three times 15 min with TBS-T  
 Detection (see Chapter II.4.4)  
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 If desired, blots can be stripped by shaking 20 min in 50 ml stripping buffer in a 
50°C water bath washed with water, shake for 20 min in blotto and reused again 
for detection with another antibody  
 
Stripping buffer:  
 
100mM  ß-Mercaptoethanol  
2%   SDS 
62,5mM  Tris/HCl pH6,7 
 
Anode buffer 1:      Anode buffer 2:  
0,3M   Tris base    25mM   Tris base 
20%   Methanol (v/v)    20%  Methanol (v/v)  
 
Cathode buffer:  
25mM   Tris base 
40mM   6-Amino-n-Hexanoic acid  
 
 
4. Detection of immunocomplexes - Enhanced chemiluminescence (ECL)  
 
 Prepare working solution by mixing equal volumes of the peroxide solution and the 
luminol/enhancer solution of SuperSignal West Pico Chemiluminescent Substrate 
(Pierce); gently overlay about 1.5ml of the mixture on the membrane 
 Incubate blot with working solution for 5min in the dark, remove detection reagents 
and wrap membrane into Saran Wrap. 
 Expose on X-ray film (Kodak) for various times to get optimal exposure. 
 
 
5. Western blot analyses by the MiniProteanII Multiscreen Apparatus 
(BioRad).  
 Clean and dry the multiscreen apparatus and gaskets prior to assembly. 
 Plase the sealing gasket onto the base plate with the raised surface down, using 
the guide pins to help align the gasket. 
 Lay the blocked blot with the antigen side facing up.  
 Place the sample cover on the top of the membrane. Finger tighten the four 
screws. Use the diagonal crossing partner to insure even pressure on the 
membrane. The multiscreen apparatus is ready for the sample application.  
 Load different antibodies or different dilution of the sera (diluted in 5% milk diluted 
in 1x TBS and 0,1% Tween-20) into the channels. Pipet the samples carefully and 
avoid trapping bubbles inside the channel.  
 Fill the channel with 600µl solution.  
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 Incubate 1h by shaking at the room temperature or overnight at 4°C. 
 Wash solution can be applied as well as antibody solution with a pipet. Use also 
600µl for each wash; wash three times. Antibody and wash solution can be rapidly 
removed by vacuum aspiration.  
 Incubate for 1h at the roon temperature with the secondary antibody diluted in 
TBS-T. 
 Wash three times for 15 min with TBS-T before detection. 
 
 
6. Protein determination by the Bradford method  
 
 Prepare BSA standard solutions (5 μg, 15 μg, 20 μg, 30 μg, 40 μg) and sample  
tubes (1 μl). Fill up with water to a total volume of 800 μl.  
 Add 200 μl of Bradford color reaction solution (BioRad) to each tube, vortex-mixing 
immediately and let stand for 10 min at room temperature  
 Measure absorbance at 595 nm  
 Draw standard curve on and calculate protein concentrations of samples  
from the graph; the standard curve is linear up to about 30 μg of BSA  
 
 
 
7. Preparation of C. albicans TCA extracts for immunoblotting 
 
 Harvest cells of 5ml yeast-culture with OD600 ~ 0,8 – 1 by spinning 5min at 
3000rpm; resuspend cells in 1ml H2O 
 Add 150µl Yex-lysis buffer, vortex-mixing and incubate 10min on ice 
 Add 150µl cold 50% TCA (trichloracetic acid) and incubate at least 10min on ice 
 Spin 5min at 13000rpm and 4°C, discard supernatant and spin again 
 Wash pellet with 1ml ice-cold 3% TCA; spin again 10min at 4000rpm (4°C) 
 Take off the rest of the supernatant carefully  
 Neutralize by adding 15µl unbuffered 1M Tris and resuspend pellet in sample 
buffer (20µl / 1OD600) 
 Incubate 15min at 37°C on shaker 
 Spin down cell debris at 13000rpm for 5min and load 10µl (0.5 OD600) of 
supernatant on SDS-PAGE gels 
 
Yex-lysis buffer: 
 
1,85M  NaOH 
7,5%  ß-mercaptoethanol (v/v) freshly added 
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Protein sample buffer: 
 
40mM  Tris/HCl pH6.8 
8M  Urea 
5%  SDS (w/v) 
0,1mM  EDTA 
1%  ß-mercaptoethanol (v/v) freshly added 
0,1g/l  bromphenol blue 
 
 
 
8. Protein extracts 
 
 Dilute overnight culture (the overnight culture should have OD600 ~13) 1:10 and let 
them grow to OD600 of 0,8 
 Induce or not the promoter   
 Induction with 10% FCS (37°C) for 2-3h or 0,3M NaCl, pH8 (30°C) for 1h 
 Not induced samples  30°C  
 Harvest the cells by centrifugation for 5min at 4000rpm 
 Wash cells with 20ml cold water, centrifuge again 
 Resuspend pellet in 300µl buffer and transfer to 2ml eppendorf tube with screw 
cap 
 Add 250µl glass beads and protease inhibitor cocktail (Roche) 
 Break the cells with Fast Prep, 3x15 sec at level 6, on ice in between 
 Spin down beads and cells debris for 3 min at 6000rpm 4°C 
 Take off supernatant and spin again for 20min at 15000 4°C 
 Take off supernatant   
 Measure protein concentration 280nm, dilution 1:200 
Buffer A: 
50mM  HEPES pH8 
0,4M  (NH4)2SO4 
1mM EDTA 
5%  Glycerol 
Proteinase inhibitor (Roche) 
 
Lysis buffer: 
50mM  Tris-HCl pH7.4 
5mM  EDTA 
150mM  NaCl  
1mM  PMSF 
Proteinase inhibitor (Roche) 
 
9. Cellular fractionation 
 
 Dilute the overnight culture 1:100 (in 10ml medium) and let the cells grow for 4 
hours 
 Let yeast grow at 30°C to an OD600 of 1 induce if necessary ( see induction 
chapter II.4.7) and let grow for the optimal time 
 Spin down 5min at 3000rpm 
 Wash I:  resuspend cells in 1ml PreT buffer, spin again  
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 Wash II: resuspend cells in PreT buffer, incubate them at 30°C for 20min under 
gently shaking, spin down  take an aliquot (wash fraction) 
 Resuspend the pellet in PreT buffer containing 5mM DTT and incubate for 20 min 
at 30°C under gently shaking, spin down  take an aliquot (DTT wash fraction) 
 Resuspend the cell pellet in 300µl Lys-buffer, add glass beads  
 Break the cells with Fast Prep, 3x15 sec at level 6, on ice in between 
 Spin down beads and cells debris for 3 min at 6000rpm 4°C  transfer 
supernatant into new tube  take an aliquot (crude lysate fraction) 
 Wash pellets twice with Lys-buffer, (spin 10000rpm, 5min, 4°C) and resuspend in 
this buffer,  take an aliquot (cell wall fraction) 
 Dilute cell wall fraction 1:1 with Digest buffer incubate for 10 min, separate cells 
from the buffer by centrifugation 
 Wash pellet tree times with with H2O 
 Incubate pellet with laminarinase at a final concentration of 0.25 unit/ml twice for 1 
h at 37°C 
 
PreT buffer: 
 
100mM     sodium acetate pH8.0 
5mM         EDTA 
Protease inhibitor (Roche) 
 
 
PreT buffer+ DTT: 
 
100mM        sodium acetate pH8.0 
5mM            EDTA 
5mM            DTT 
Protease inhibitor (Roche) 
 
 
Lys-buffer: 
 
50mM      sodium acetate pH5.5 
150mM    NaCl 
5mM        EDTA 
1mM        phenylmethylsulfonyl fluoride 
(PMSF) (added freshly)  
Protease inhibitor (Roche) 
 
Digest buffer: 
 
50mM          Tris HCl pH8 
100mM        EDTA 
2%               SDS 
 
 
 
Laminarinase buffer: 
 
100mM        sodium acetate pH5,5 
1mM            EDTA 
+ Laminarinase [0,25u/ml] 
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10. Purification of GST fusion protein from E.coli 
 
Checking for optimal induction time 
 First, pick about 3 single E.coli clones and check for induction of fusion protein 
expression. 
 Induction in total extracts: 
 Dilute overnight culture in fresh LB-Amp to OD600 0,25-0,5 
 Make up 12ml liquid culture of OD600 0,25-0,5 equilibrate for 15min at 30° C 
 Take a 1,5ml control sample at 0min as the uninduced control  
 Induce by adding IPTG to a final concentration  of 0,2mM at 30°C  
 Take 1,5ml samples at 20, 40, 60, 90, 120 and 180min after induction 
 Spin down samples (full speed 5min) in eppendorf tubes and aspirate supernatant 
with the pipette  
 Resuspend pellet in protein sample buffer 
 Boil on heat block 95°C for 10min 
 Spin down at 13000rpm 15min (transfer supernatant to new eppendorf tube) 
 Run 0,5- 1 OD600 equivalent of the total extract on SDS-PAGE gels  
 Stain with Commassie blue  
 
Determinate if GST fusion-protein is soluble or not: 
 Grow culture of OD600 0,5 exactly as describe above and incubate 15min at 30°C 
 take sample from not induced sample 
 Induce with IPTG for the optimal time (80min)  
 Spin down cells in Sorvall centrifuge for 10min at 7000rpm and wash once with 
cold PBS on ice! 
 Suspend cells in 2ml cold PBS and lyse cell suspension by sonication 8x 10imp. 
 Spin homogenate for 10min at 7500rpm in Sorvall centrifuge at 4°C to bring down 
insoluble inclusion bodies 
 Take sample from supernatant (soluble fraction) and add sample buffer  
 Resuspend insoluble fraction in sample buffer  
 Boil all samples for 10min at 95°C and run 0,5-1 OD600 extract equivalents of 
samples in SDS-PAGE gels  
 Stain with Commassie blue 
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Binding of GST fusion-protein to glutathione sepharose beads: 
 Grow E.coli strain containing the desired plasmid in 5ml LB+Amp at 37°C 
overnight 
 Dilute preculture in 500ml LB+Amp to OD600 0,2 and grow for 1h at 37°C 
 Shift culture to 30°C and grow to OD600 0,5  take an aliquot 
 Induce expression of GST fusion-protein by adding 0,2mM IPTG 
 Let grow for 80min at 30°C  take aliquot  
 Harvest cells by centrifugation at 4000rpm for 5min in a GS3 rotor in a Sorvall 
centrifuge 
 Resuspend pellet in 7ml TpG buffer and add 1mM DTT and protease inhibitor 
cocktail (Roche) 
 Lyse cells by sonication ( 3x30sec, 30sec on ice in between)  take aliquot  
 Spin down cells debris at 4°C for 10min at 13000rpm in eppendorf tubes  
 Equilibrate glutathione sepharose beads in TpG buffer (wash in TpG buffer, spin 
down 5min 2000rpm) 
 Add 400µl 50% glutathione sepharose beads to cell lysate and incubate overnight 
on rotation mixer  take aliquot next morning 
 Centrifuge at 3000rpm for 2min at 4°C and wash beads twice with TpG buffer ( 
keep supernatant) 
 Elute GST fusion-protein by shaking beads 20 min at RT with 500µl elution buffer 
 Spin down beads 1min at 3000 rpm and repeat elution twice 
 
Elution buffer: 
 
50mM   Tris/HCl pH7,5 
5mM   gluthation (sterile filtrated) 
 
 
 
TpG buffer: 
 
20mM   Tris/HCl pH8,0 
100mM  NaCl 
1mM   EDTA 
0,1M   ZnCl2 
0,5%   NP40(v/v) 
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11. Preparation of rabbit antiserum 
 
 Leave the fresh blood for several hours at RT to let it coagulate. 
 Spin the coagulated blood for 20min at 4000rpm and 4°C. 
 Sterile-filter the serum through a 0,45µm filter. 
 To avoid phosphatase activity, heat-inactivate the serum at 56°C for 30min in a 
shaking waterbath. 
 Add 0,02% of sodium azide to preserve the serum. 
 If antibodies will be used later on for Western blotting or immunofluorescence the 
serum can be stored frozen in 50% glycerol at -80°C. If serum will be lyophilized, 
or used for further purification, e.g. IgG fractionation, or for immunoprecipitations 
freeze them without glyzerol. 
 
 
12. Affinity purification of polyclonal antibodies 
 
 Run a gel with 100-300µg of GST fusion protein 
 Transfer to nitrocellulose membrane 
 Stain for ca. 10 min with Ponceau  
 Cut the band of interest and cut it in small pieces, put them to an eppendorf tube  
 Incubate with ~ 1ml of serum overnight at 4°C  
 Keep the supernatant  
 Washing :    1x 1ml 10mM Tris pH8,0 
1x 1ml 10mM Tris pH8,0 + 0,5 M NaCl 
 Prepare eppendorf tubes with 50µl 1M Tris/HCl pH8,0 to neutralize the elution 
fraction 
 Elution: 3x 200ml 100mM Glycin pH2,5  2min incubation by rotation 
 Test for neutral pH 
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II. 5. Mammalian Cell Culture 
 
1. Primary culture of bone marrow-derived macrophages (BMDMs) 
 
All given volumes are calculated for the limbs of one mouse and should be increased 
according to the number of limbs. 
 On day 1, sterile dissect tibias and femurs from a 6-8 week old mouse, quickly 
rinse bones in 70% ethanol and place in 15ml ice-cold sterile PBS. When all the 
limbs are collected, transfer them in fresh 15ml ice-cold sterile PBS and keep on 
ice. (Older mice can be used but the number of bone marrow cells recovered will 
be smaller.) 
 To flush out the bone marrow, separate femur from tibia at the knee joint. Holding 
the bone with forceps above a sterile dish, cut one extremity of the bone and using 
a 20-ml syringe with a 27GX3/4 needle, flush DMEM with 10% FCS, 100 U/ml 
Penicillin and 100µg/ml Streptomycin, into the medullary cavity until no more cells 
are coming out. 
 Collect bone marrow suspension and keep it on ice until all bones have been 
processed. Bone marrow flushing should be performed under as much as possible 
sterile conditions as required for cell culture. 
 To prepare BMDMs, centrifuge the collected bone marrow at 1000xg for 5min and 
re-suspend the pellet in 44ml BMDM medium. Distribute the cell suspension 
equally in four 10x10cm Petri dishes (or seven Ø10cm-Petri dishes); transfer to a 
37°C-incubator with a 5% CO2, 95 % humidity atmosphere. Only BMDMs will 
adhere to non-tissue culture treated plastic, allowing for their separation from other 
cell types, the latter being eliminated when media are changed. 
 On day 2, add 6-8ml of BMDM medium. Check for cell density every day. 
 On day 4-5, when the plate is getting confluent, aspirate the media containing non-
adherent cells, collect the cells gently by scrapping the plates with a soft rubber 
spatula and re-plate at a ratio of 1:2-1:3 in square 10x10cm Petri dish 
(Alternatively, 4-days BMDMs can be frozen in FCS with 10% DMSO and stored in 
liquid nitrogen until further need. They should then be grown for at least 6-7 days 
in BMDM media before use.) 
 Culture cells grow for another couple of days, change medium completely every 2-
3 days. 
After 9-10 days of culture, BMDM cell surface markers should be checked by FACS 
before performing interaction experiments. 
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BMDM media: 
 
Dulbecco’s modified Eagle’s Medium DMEM, high glucose (4.5g/l), 
with L-Glutamine, without pyruvate (PAA) 
+ 10%   FCS 
+ 100 U/ml  Penicillin 
+ 100 μg/ml Streptomycin 
+ 20%  L-conditioned media 
 
 
 
2. Preparation of L-conditioned media 
 
 Divide ten confluent diameter-10cm dishes with CSF-1 producing L929 cells 
(ATCC# CCL-1) into twenty 175cm2-flasks with 50ml/flask of high-glucose DMEM 
supplemented with 10% FCS without antibiotics. 
 After 2-3 days, when cells are approximately 70% confluent, aspirate the medium 
and replace with 100ml/ flask of starving medium (high-glucose DMEM without 
FCS and antibiotics). 
 After 10 days, collect and filter the conditioned media on Steritop 0,22μm GP 
express PLUS membrane (Millipore, Billerica, MA, USA), to prevent membrane 
clogging. Store 200ml aliquots at -20°C. Keep a small aliquot at 4°C for testing.  
 
Testing L-conditioned media 
 Flush the bones of one mouse as described before, divide the cells into five 
100x100 square petri dishes. 
 Grow in 11ml of BMDM medium supplemented with 0, 10, 15 and 20% of the fresh 
batch of L-conditioned medium. As a positive control, also grow two plates in 
BMDM medium supplemented with the optimal concentration of an old working 
batch of L-conditioned medium. 
 After 2-3 days, add 6ml of new medium.  
 After 5-6 days, count the cells at each concentration, split the cells 1:3. Let them 
grow until confluent and count again. Change the medium every 2-3 days. Deduce 
from the cell count the optimal L-conditioned medium concentration. 
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3. End point dilution assay 
 
Day1 
 Log phase BMDMs cells (day 11-12) are suspended in culture medium (-L-cond 
DMEM + Glutam + FCS) at 1x106 cells/ml the day before usage  
 Distribute 100-µl aliquots in a 96-well cell culture plate 1x105  /well in every second 
column  
Day2 
 Wash C. albicans two times with 10 ml PBS, 
 Resuspend C. albicans in 1 ml DMEM +Glut wo FCS 
 Count 1:900 dilution with CASY 
 Dilute in DMEM  to 2 x 106fungi/ml C. albicans in DMEM, 
 Make ¼ serial dilutions in 150 µl (150+50) 
 Add C. albicans to the 96well plate +/- BMDMs . 
 
Plate Setup: plate 1-9 
 BMDM  BMDM  BMDM  BMDM  BMDM  BMDM  
 1:1 1:1 1:4 1:4 1:16 1:16 1:64 1:64 1:256 1:256 1:1024 1:1024 
Strain 1             
Strain 2             
Strain 3             
Strain 4             
Strain 5             
Strain 6             
Strain 7             
Strain 8             
 
 
4. Crystal violet staining 
 
 Wash cells 3 times with 200µl PBS 
 Add 50µl of 0,2% crystal violet, 20% methanol solution 
 Incubate for 20min at room temperature 
 Wash 3 times with 200µl PBS 
 Air dry plate 
 
5. ROS assay 
 
C. albicans strains: 
 Check C. albicans overnight culture for contamination under microscope 
 Measure OD600 (1/50 dilution) 
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 Dilute C. albicans in 25ml YPD to OD600~0,2 and incubate at 30°C 
 Harvest cells by centrifugation at 2500rpm, 5min, RT, when growth reaches OD600 
~1 (after ~3,5-4h) 
 Wash cells with 40 ml PBS, spin again (2500 rpm, 5min, RT) 
 Resuspend pellet in 1ml HBSS 
 Dilute cells 1:10 in 1,5ml HBSS and measure cell concentration with CASY  
Immune-cells: 
 Harvest log-phase BMDMs  45min before the assay starts (resuspend cells in 
HBSS) 
 Dilute in HBSS w/o Phenol Red w/o FCS to reach a final dilution of 4x105/ml in 
about 10ml 
 Count with CASY, keep in water bath at 37°C 
 
Interaction: 
 Distribute 100µl of immune-cells in 96 well-plate 
 Incubate them at 37°C for 10-30 min 
 Add 50μl HBSS with or w/o stimulus 
 50μl Reaction-mix (5,5ml HBSS+11μl luminol (0,1M stock)+220μl HRP(2000IU/ml) 
 Measure chemiluminescence for at least 120min in 2,5 min intervals in Wallac 
1420 VICTOR™ Multilabel counter. 
 Luminescence is expressed as relative luciferase units/minute/1000cells 
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III. Results 
III. 1. Promoter activity studies of SOD proteins 
  
1. Expression of green fluorescent protein under the constitutive and gene 
own promoter 
Before localisation studies can start, we had to study the expression of Sod5 protein. In 
general, to study the promoter activity of C. albicans Sod proteins, we designed strains 
with XFP-tagged SOD4, SOD5 and SOD6 promoter and XFP-tagged actin promoter as a 
positive control. Using the strains with XFP-tagged SOD promoters, we were able to 
detect the promoter activity via the expression of the XFP proteins. During my work I was 
especially interested on Sod5. The constructs with the fluorescent proteins expressed 
under the SOD4 and SOD6 promoters can be used in further studies. 
It has been shown that SOD5 is induced during yeast to hyphae transition 
(Nantel et al., 2002). There are different possibilities to induce yeast to hyphal transition in 
yeast, like serum, increased pH, and increased temperature. The presence of serum in 
yeast media causes an induction of SOD5 gene. This increase is even higher if the 
temperature is 37°C. According to the literature, SOD5 is induced in response to 
neutrophils (Fradin et al., 2005). SOD5 is also up regulated under a number of other 
conditions like oxidative and osmotic stress (Martchenko et al., 2004) . 
The following strains were constructed: CFP and GFP were separately cloned 
behind the actin promoter and transformed either into the SN152 strain or into SNR34R 
strain (strains can be found in the attachment, see stains used for this study). To study the 
promoter activity of SOD4, SOD5 and SOD6, we cloned YFP behind SOD4 promoter, 
CFP and GFP behind SOD5 and GFP behind SOD6 promoters and transformed those 
constructs into the SN152 strain. Additionally we transformed the PSOD5-CFP construct 
into SNR34R strain.  
The fluorescent protein cassettes were amplified from pMG1646, pMG1656, 
pMG1801 plasmids kindly provided by J. Berman (plasmid maps can be found in the 
Appendix). Amplified plasmid cassettes include the coding sequence for one of the 
fluorescent proteins and the HIS1 gene for selection.   
PCR amplification on the example of PSOD5-GFP construct: for amplification of 
PSOD5-GFP sequence we used F1.1CaSod5 and R2CaSod5 primer. With these primers, 
we introduced the overlapping sequence into the PCR product, enabling us the insertion 
of the construct via homologous recombination behind the SOD5 promoter (Fig.III.1.1). 
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The amplification was done with a polymerase with proofreading activity, the phusion 
polymerase. The amplified fragments (Fig.III.1.2) were used to replace one allele of the 
target gene (Fig.III.1.1). 
 
 
 
Fig.III.1.1 A schematic overview of Sod5 promoter-tagging.  
A. Fragment used for transformation was PCR amplified using the F11CaSod5 and R2CaSod5 primers.  
B. The SOD5 sequence is replaced by GFP and HIS1 via homologous recombination of the flanking reagions. 
 
 
 
Fig.III.1.2. : PCR Products for transformation 
PCR products were amplified using F1.1 CaAct and R2 CaAct or F1.1 CaSod5 and R2 CaSod5 or F1.1 
CaSod6 and R2 CaSod6. Primers from pMG1646, pMG1656, pMG1801 plasmids. Plasmids and separated on 
a 1% agrarose gel to check for amplification efficiency. 
 
We used our construct to investigate the expression of the SOD5 gene under 
different conditions (see below). We performed experiments to induce the promoter and to 
compare the expression rate. The condition inducing the strongest activity was used in 
further experiments.  
The promoter induction with FCS and NaCl, pH8 was done in different ways. 
For the induction with 10% FCS, we diluted the overnight culture 1:100, grew cells for 1h 
at 30°C and than added 10% FCS and switched to 37°C for another 3h. For the induction 
with NaCl and pH, we grew diluted overnight culture for 3h at 30°C to OD600 = 0,8 and 
replaced media by YPD with pH8 (NaOH) and 0,3M NaCl for 1 hour.   
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We confirmed previous findings that the SOD5 promoter is induced with 
increasing pH in YPD and by adding of NaCl at the final concentration of 0,3M 
(Martchenko et al., 2004). (Fig.III.1.3). These conditions mimic the environment inside the 
phagosome where we have both: increased pH and increased salt concentrations. The 
highest induction of SOD5 under this condition is explainable through superoxide 
dismutase activity in defence against phagosome-mediated killing. SOD5 is upregulated 
during phagocytosis (Fradin et al., 2005). 
 
Fig.III.1.3 Comparison of different conditions for SOD5 promoter induction 
TCA protein extracts were performed and separated on a 10% SDS Page, an equivalent of 0,5 OD600 was 
loaded on each lane, from left to right: (1) wild type, (2) strain with GFP behind the SOD5-promoter untreated, 
(3) PSOD5-GFP grown at 37°, (4) grown at 30° with 10% FCS,  (5) grown at 37°C and 10% FCS, (6) grown at 
30°C and 0,3M NaCl, (7) at 30°C and pH8, (8) grown at 30°C and pH8 and 0,3M NaCl. GFP fusions were 
detected with an anti- GFP monoclonal antibody (Roche), to assess equivaltent loading anti-PGK antibodiy 
was used (kindly provided by Karl Kuchler).  
 
According to these results the SOD5 promoter is highly induced under osmotic 
and pH stress. In our future experiments, we induced SOD5 promoter with 0,3M NaCl and 
pH8.  
A Candida strain expressing PSOD5-GFP was used for the detection of the 
promoter induction under the fluorescent microscope.  The promoter was induced with 
0,3M NaCl and ph8, and we were able to detect expression of GFP in the PSOD5-GFP 
strain after the promoter induction. The same strain without induction of SOD5 expression 
delivered no fluorescence signal (Fig.III.1.4).  
 
 
Taken together, we were able to construct a C. albicans strains expressing 
XFP proteins under constitutive or SOD promoters. Using the strain expressing PSOD5-
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GFP, we confirmed previous findings about the SOD5 promoter induction under osmotic 
stress and increased pH.   
 
A. 
 
 
 
 
 
 
 
B. 
 
 
Fig.III.1.4 Microscopy pictures.  
A. KY-Ca010 strain (PSOD5-GFP) not induced in eGFP filter and in transmission.  
B. KY-Ca010 strain (PSOD5-GFP) induced by yeast media with pH8 and 0,3M NaCl.  
Slides were observed in eGFP and in contrast phase filters. Cells were not fixed and observed direct after 
promoter induction. 
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III.2. Studies of Sod5 localization 
 
1. Internal tagging of Sod5 with green fluorescent protein (GFP) 
 
Cloning strategy  
To determine the subcellular localization of Sod5 in cells, and also for the 
immunodetection of Sod5 protein on Western blots, we decided to tag Sod5 with the 
fluorescent protein. We constructed in frame fusion of a green fluorescent protein (GFP) 
that had been engineered for optimal expression and quantum juld in C. albicans.  
Sod5 is a GPI-anchored protein; therefore we had to consider the localization 
signal sequences at the both termini of Sod5. Precursors of GPI-anchored proteins have a 
classical signal sequence for the import into the ER at their N-terminus and a C-terminal 
signal for GPI anchor (Fig.III.2.1). Both signals are cleaved after transport and GPI 
targeting, therefore a classical tagging on either the C- or N-terminus is impossible. GFP 
was then inserted at the N-terminus of protein after the first 16 amino acids or at the C-
terminus before the C-terminal 37 residues.  
       
  
Fig.III.2.1 Schematic overview of Sod5 GFP-tagging.  
Two different positions were chosen for tagging of Sod5 with GFP. On the N-terminal site GFP was introduced 
behind the 48th nucleotide; on the C-terminal site GFP was cloned behind the 576th nucleotide.  
For the homologous recombination of Sod5-GFP into the corresponding 
genomic locus, we used the pSFS2a-Sat1-FLP plasmid (Reuss et al., 2004). The SAT1-
flipping plasmid pSFS2a-Sat1-FLP contains a dominant nourseothricin resistance marker 
(caSAT1) for the selection of transformants, and a C. albicans-adapted FLP gene under 
control of a maltose promoter that allows the subsequent genomic excision of the 
cassette, because it is flanked by FRT target sequences. FLP-mediated excision of the 
SAT1 flipper cassette is achieved by simply growing transformants in a medium 
containing maltose, activating the maltose promoter PMAL2. This results in expression of 
the flippase and leads to excision of the nourseothricin resistance marker. As a control for 
positive transformants, cells were plated on YPD medium and YPD-Nat medium. The 
flipping was successful in colonies unable to grow on YPD-Nat plates.  
 
SOD5
Promotor 
GFP 
48 576
GFP or
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We amplified the SOD5 gene sequence and 500bp promoter from genomic 
DNA of the SN152 strain using the oligonucleotides 55_caSOD5 and SOD5_ct_Not 
(sequence can be found in the Table1 p.78-80). For amplification, we used Phusion 
polymerase to avoid mutations in the coding sequences. We cloned the amplified SOD5 
PCR product into the pGEMT vector resulting in pGEMT-Sod5ct. The next step was 
performed to introduce restriction sites into SOD5. Since we had two different positions for 
the GFP insertion, we used either the Sod5-KasI-48s and the Sod5-KasI-48as primers for 
the KasI restriction side insertion behind the first 16 amino acids or the Sod5-KasI-575s 
and the Sod5-KasI-575as primers for the restriction side insertion before the last 37 
residues. The GFP gene was amplified and KasI restriction sites were introduced at the 
ends. The amplified pGEMT-Sod5ct vector and GFP were digested with KasI and ligated. 
The correct vector : insert ratio was calculated(Fig.III.2.2.a): 
 
 
 
Fig.III.2.2a. Formula for calculating the optimal vector to insert ratio for ligation.  
 
Fig.III.2.2b. Vector and insert.  
pGEMT-Sod5 (3713bp) vector digested with KasI and phosphatase treated and GFP (714bp) digested with 
KasI were separted on a 1% agarose gel.  
 
We transformed the pGEMT-Sod5-GFP vector into competent E.coli and 
checked the constructs via colony PCR and sequencing. The pGEMT-Sod5ct plasmid and 
the pSFS2a-Sat1-FLP were digested with restriction enzymes NotI and SacI and the 
1949bp SOD5-GFP fragment was gel purified and ligated with pSFS2a-Sat1-FLP vector 
(7488bp). Before ligation the pSFS2a-Sat1-FLP vector was treated with phosphatase.  
The next step was to bring the 3’SOD5 fragment into pSFS2a-Sod5-GFP 
vector. We amplified 3’SOD5 fragment in the first PCR, pSFS2a-Sod5-GFP in the second 
and fused these two fragments in the third PCR reaction (Fig.III.2.3). For amplification of 
the 3’SOD5 region we used FRT-S5term and 33CaSod5 primers. The pSFS2a-Sod5-GFP 
vector fragment was amplified with 55CaSod5 and FRT-f.  
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Fig.III.2.3. Schematic image of the end construct that was used for the transformation.  
In the final PCR reaction, the SOD5-GFP fragment was fused (amplified with 55CaSod5 and FRT-f primers) 
with the SOD5-terminator fragment (amplified with FRT-S5term ans 33CaSod5 primers).  
 
We fused 3’SOD5 and pSFS-2a-SOD5-GFP fragments in the third the Phusion 
polymerase PCR reaction with an increased MgCl2 concentration [3mM]. The PCR 
product was transformed into the competent sod5Δ/Δ SN152 and into the wild type control 
strain. The correct genomic integration into the corresponding locus was verified by colony 
PCR (Fig.III.2.4). The strains carrying positive constructs were inoculated in maltose to 
loose the SAT1 cassette. Futhermore, strains were also inspected by Southern blot 
analysis for the correct genomic integration (data not shown).   
 
 
 
Fig.III.2.4. Colony PCR performed to identify positive transformants.  
Using 5CaSod5 and YFP_100as primers for the 5’-prime end and 3CaSod5 and SAT108a primers for the 3’-
prime end, we were able to identify two positive transformants for each internal tagging construct. Number 6 + 
8 for N-terminal and 1 + 4 for C-terminal tagged construct. 
 
We had two positive construct for the N-terminal tagged Sod5 and two positive for the C-
terminal tagged construct. 
The constructs with the N-terminal tagged Sod5-GFP (KY-Ca010), which were picked for 
further studies, were named clone 6.8; clone 6.10; clone 8.8 and clone 8.10.  
The constructs with C-terminal tagged Sod5-GFP, which were used for further studies, 
were clone 1.1; clone 1.15; clone 4.4 and clone 4.13. 
 
 
 
 
 
SOD5‐GFP 5 3SAT‐Flp 3’SOD5 
FRT 
down 
FRT 
up 
FRT-S5term 55CaSod5 
FRT-f 33CaSod5 
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2. Determination of Sod5-GFP functionality 
 
Reactive oxygen species (ROS) assay 
To determine whether the Sod5-GFP fusion proteins are functional, we 
performed a ROS assay. As published by our group C. albicans Sod5 plays an important 
role in defence against oxidative stress and is able to convert harmful superoxide from 
macrophages into H2O2 (Frohner et al., 2009). Hydrogenperoxide can be then converted 
to H2O and O2. The ROS assay was established to measure the accumulation of 
superoxides and other ROS during the innate immune response to C. albicans.  
For the ROS assay, we used a luminol-dependent chemiluminescence assay. 
During the infection of macrophages with C. albicans, NADPH oxidase is activated, which 
leads to rapid ROS production (DeLeo et al., 1999). Luminol is a chemical that exhibits 
chemiluminescence, when mixed with an appropriate oxidizing agent. In other words, the 
oxidation of luminol by ROS leads to chemiluminescence. Luminol is used to measure 
total ROS. The chemiluminescence is proportional to the amount of ROS produced.    
Zymosan is a cell wall component of the yeast S.cerevisiae known to induce 
ROS. For this reason, zymosan was used as a positive control for ROS assays. The 
signal can be detected by a luminescence plate reader (Wallac 1420 VICTOR™ Multilabel 
counter).   
The ROS assay was established in our lab to study the role of C. albicans 
superoxide dismutases, especially Sod4, Sod5 and Sod6, in the defence of C. albicans 
against host immune system. We used this assay to prove the functionality of Sod5-GFP 
protein. The accumulation of superoxides was compared between the wild type strain, 
sod5Δ/Δ strain, sod5Δ/Δ::SOD5 and sod5Δ/Δ::SOD5-GFP strains. The experiment was 
carried out as follows: 100µl from a 4x105 /ml BMDM cell suspension were distributed to 
each well of 96-well plate. C. albicans strains were washed in PBS, diluted in HBSS and 
distributed to the wells. C. albicans induces ROS in BMDMs at an MOI (multiplicities of 
infection) from 2:1 to 10:1 (fungi to macrophages). For our experiment, we used an MOI 
5:1 and 2,5:1. Zymosan (100µg/ml) was used as a positive control. Afterwards, 50µl of 
HBSS containing 200µM luminol and 4U HRP were added to start the reaction. 
Chemiluminescence was measured at 2,5min intervals in WallacVictor3 plate reader for at 
least 90min.  
For our experiment, we expected the same ROS levels in sod5Δ/Δ:SOD5 and 
sod5Δ/Δ:SOD5-GFP when Sod5-GFP is functional protein. As expected, we observed no 
increased ROS accumulation in macrophages co-cultured with sod5Δ/Δ:SOD5-GFP strain 
at an MOI 2,5:1 (Fig.III.2.5.A). The ROS accumulation was similar to ROS levels during 
infection with the wild type strain or sod5Δ/Δ:SOD5 revertant strain. At this MOI the 
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functionality of sod5Δ/Δ strain was restored by Sod5-GFP protein. Sod5-GFP was still 
strong enough to detoxify the total ROS produced by BMDMs. This led us to conclusion 
that Sod5-GFP is functional. However, at an MOI 5:1, the functionality of sod5Δ/Δ strain 
was not completely restored by Sod5-GFP (Fig.III.2.5.B). The accumulation of 
superoxides in sod5Δ/Δ:SOD5-GFP was higher than that in the sod5Δ/Δ:SOD5 strain, but 
lower than in sod5Δ/Δ strain.  
The higher ROS levels at an MOI 5:1 might be explained due to the fact that 
the extracellular tag with GFP is increasing ROS, because ROS can be generated by GFP 
(Goto et al., 2003). We performed a survival assay to confirm the results obtained with the 
ROS assay. 
 
 
 
Fig.III.2.5. ROS accumulation during infection with C. albicans. 
A-B. ROS measurement by luminal-dependent chemiluninescence at 37°C in 2,5min intervals.  
A. ROS accumulation after stimulation of BMDMs with wild type, sod5Δ/Δ (CA-IF019), sod5Δ/Δ::SOD5 
revertant strain (CA-IF027) and sod5Δ/Δ::SOD5-GFP (KY-Ca010) strains at an MOI 2,5:1. Similar levels of 
ROS are observed in wild type, sod5∆/∆::SOD5 and in two different clones from sod5∆/∆::SOD5-GFPstrain.   
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B. The figure shows the ROS accumulation during the infection with the same strains at an MOI 5:1. The ROS 
levels by sod5∆/∆::SOD5-GFP strain clones are higher compared to wild type strain but still lower compared to 
the sod5∆/∆::SOD5 strain. 
C. Stimulation of BMDMs with wild type, sod5Δ/Δ (CA-IF019), sod5Δ/Δ::SOD5 revertant strain (CA-IF027) 
SOD5-GFP (KY-CA011) and sod5Δ/Δ::SOD5-GFP (KY-Ca010 clone 4.4) at an MOI 2,5:1.  
D. Quantification of the total ROS release between 10 and 50 min by calculating the area under the curve (moi 
2,5:1). The highest accumulation was detected by sod5Δ/Δ (CA-IF019) deletion strain, the strains with SOD5-
GFP showed small differences in ROS accumulation compared to the wild or revertant strain.  
 
End point dilution assay 
 
In addition to the ROS assay, we also used the end point dilution assay to 
prove the functionality of the Sod5-GFP protein. Sod5 is important for the detoxification of 
superoxide anions produced by macrophages during the phagocytosis. If Sod5 is 
functional it helps C. albicans to survive in the interaction with macrophages. Therefore, 
this protein has a direct role in the protection of C. albicans against oxidative stress.  
To analyze the survival rate of C. albicans cells exposed to macrophages, we 
used an end-point dilution survival assay. This survival assay is based on the simple 
counting of viable C. albicans colonies after the interaction with macrophages. Colonies 
are visible two days after infection of BMDM with C. albicans stains in wells with the 
highest dilution of C. albicans. They can be counted and compared between the different 
stains used for assay. 
The experiment was carried out as follows: The overnight culture of C. 
albicans grown in YPD was washed twice in PBS, resuspended in DMEM + 10% FCS and 
diluted to 2x106 cells/ml. C. albicans suspension was diluted 4-fold in serial dilution steps. 
Fifty microliters of the suspension were added to the next well containing 150µl medium 
only or medium with macrophages. Afterwards plates were incubated for 48 h at 37°C in 
5% CO2 atmosphere. To visualize colonies, we stained them with crystal violet, using a 
0,2% solution. Colonies were counted and the amount of colonies in the wells with and 
with out macrophages were compared.  
For the experiment we used the wild type SN152 strain, the revertant strain, 
the deletion strain sod5Δ/Δ as controls and sod5Δ/Δ::SOD5-GFP strain. Three 
independent survival assays were performed. The data obtained from previous 
experiments showed that 60-70% of wild type cells are able to survive in the presence of 
macrophages. The survival rate by sod5Δ/Δ mutant is about 25-30%. The revertant 
strains have almost the same viability like the wild type. To test the functionality of Sod5-
GFP, we compared the survival rate between wild type, sod5Δ/Δ, revertant strain and 
sod5Δ/Δ::SOD5-GFP strain. We expected similar viabilities of our Sod5-GFP and the wild 
type or to the revertant strain.  
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If Sod5-GFP is a functional protein, it should restore the viability of a C. 
albicans sod5Δ/Δ deletion strain. In our assay, we could not observe any significant 
differences between the wild type, the revertant and the Sod5-GFP strains. This led us to 
the conclusion, that Sod5-GFP is a functional protein. The viability of Sod5-GFP strains 
was similar to the wild type and revertant strains.  
 
 
 
 
Fig.III.2.6. End-point dilution assay. Co-incubation of wild type macrophages with different C. albicans 
strains. Strains with re-integrated Sod5-GFP were tested for their viability compared to wild-type and to the 
sod5Δ/Δ::SOD5 strain. We used wild type and sod5Δ/Δ  strains as a control. The viability of the strains was 
defined through counting and comparing of the equivalent dilution from the viable colonies and colonies 
survived after the incubation with macrophages. The viability of wild type C. albicans exposed to macrophages 
is about 80%. The Sod5-GFP strains show similar viability of about 70-80%. 
A. Figure shows strains tagged on the N-terminus (KY-Ca010 clones 6 and 8) 
B. Figure shows strains tagged on the C-terminus of the protein (KY-Ca010 clones 1 and 4). We tested a wild 
type strain heterozygote Sod5-GFP allele (KY-Ca011). The behaviour of this strain was similar to Sod5-
GFP strains in sod5Δ/Δ background. 
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Fig.III.2.7. End-point dilution assay. The experiment was repeated using the higher dilution of C. albicans 
strains for counting. We co-incubated wild type macrophages with different C. albicans strains. Strains with re-
integrated Sod5-GFP were tested for their viability compared to wild type and to the sod5Δ/Δ::SOD5 strain. 
We used wild-type and sod5Δ/Δ strains as a control. The viability of the strains was defined through counting 
and comparing of the equivalent dilution from the viable colonies and colonies survived after the incubation 
with macrophages. 
A.Figure shows strains tagged on the N-terminus (KY-Ca010 clones 6 and 8) 
  B.Figure shows strains tagged on the C-terminus of the protein (KY-Ca010 clones 1 and 4).  
 
End-point dilution assay, performed to test different Sod5-GFP strains for the 
functionality of Sod5, showed that the viability of these strains is similar when compared to 
the wild-type or to sod5Δ/Δ::SOD5 strain. The viability of these strains is an important 
criterion for the functionality of Sod5 as we know that the survival rate of C. albicans 
strains lacking Sod5 is about 30% reduced in the presence of macrophages (Frohner et 
al., 2009). The viability of sod5Δ/Δ strain was restored by integration of Sod5-GFP and 
similar to the wild type. No significant differences between the two different positions of 
the GFP tag were detected. The viability of all strains was about 70%.  
 
 
3. Detection of protein localisation under the fluorescence microscope 
 
For detection of Sod5-GFP in the fluorescence microscope in the living cells, 
an overnight culture, was diluted and induced with YPD + 0,3M NaCl and pH8. Cells were 
examined under the fluorescent microscope with out any fixation with 490nm excitation 
and 525nm emission filters. Cells expressing the Sod5-GFP protein were fluorescent at 
the cell periphery as expected for GPI-anchored proteins targeted to the cell wall or to the 
plasma membrane. We were able to detect fluorescence at / or close to the cell surface. 
Cells in which Sod5 promoter was not induced, did not show fluorescence.  
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Unfortunately, the resolution of the fluorescence microscope (Fig.III.2.8) did not allow us 
to identify the exactly localization of the protein; to differ between the plasma membrane 
and cell wall. 
 
 
A.
 
C.
B.  
Fig.III.2.8. Microscopy pictures show the localisation of protein on the cell surface. Images were taken using 
Olympus cellR imaging fluorescence microscope.  
A. sod5Δ/Δ::SOD5-GFP strain (KY-Ca010 clone 6.8). The Sod5-GFP protein expression was induced 
by adding YPD media with 0,3M NaCl and pH8.  
B.  sod5Δ/Δ::SOD5-GFP strain (KY-Ca010 clone 8.8). The Sod5-GFP protein expression was induced 
by adding YPD media with 0,3M NaCl and pH8.  
C. sod5Δ/Δ::SOD5-GFP strain (KY-Ca010 clone 6.8). The expression of protein was not induced. 
 
To check whether the protein is expressed at the plasma membrane or in the 
cell wall, we used filipin to stain the plasma membrane of C. albicans and to compare the 
signal from the plasma membrane with the signal from the Sod5-GFP protein. Filipin is a 
chemical that stains specifically the cholesterol in the plasma membrane. Filipin staining 
was performed as described in Materials and Methods.  
Using the Olympus cellR imaging fluorescence microscope, we were unable to 
detect the differences between signals coming from the filipin-stained plasma membrane 
and the Sod5-GFP signal. The resolution from this microscope did not allow us to draw 
any conclusions about the localization of the protein. Detecting the filipin under the 
confocal microscope was difficult because of the fluorescent instability of filipin (Fig.III.2.9) 
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B. Fig.III.2.9 Filipin staining. sod5Δ/Δ::SOD5-GFP strain (KY-Ca010 clone 6.8) where the Sod5-GFP 
protein expression was induced by adding YPD media with 0,3M NaCl and pH8. The overlay of images from 
the Filipin stained plasma membrane and images taken in eGFP channel using Olympus cellR imaging 
fluorescence microscope showed no additional evidence about the localization of the protein.  
 
We were able to detect Sod5-GFP protein either in the plasma membrane or 
close to the cell surface, but filipin staining, as a the attempt to get additional evidence 
about the localization of the protein failed. The images taken from the filipin-stained 
plasma membrane and overlay with the images taken in the eGFP channel showed no 
conclusive results.  
 
4. Detection of protein localization using cell fractination 
First, we performed experiments to prove if we are able to detect Sod5-GFP 
protein on the Western blots. Therefore, we used TCA protein extracts from our stain, 
which were either induced or not. Detection of protein occurred by all four clones with 
Sod5 protein tagged on the N-terminus with GFP (KY-Ca010, clones 6.8; 6.10; 8.8; 8.10) 
after induction of promoted with 0,3M NaCl and pH8. PSOD5-GFP strain was used as a 
positive control for induction (Fig.III.2.10).  
 
Fig.III.2.10. TCA extracts from C. albicans N-terminal constructs for immunoblotting. Lane1: KY-Ca010 
clone 8.10 induced; lane2: KY-Ca010 clone 8.10 not induced; lane3: KY-Ca010 clone 8.8 induced; lane4: KY-
Ca010 clone 8.8 not induced; lane5: KY-Ca010 clone 6.10 induced; lane6: KY-Ca010 clone 6.10 not induced; 
lane7: KY-Ca010 clone 6.8 induced; lane8: KY-Ca010 clone 6.8 not induced; lane9: PSOD5-GFP induced. 
Induction occurred with pH8 and 0,3M NaCl. 
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Many yeast GPI-anchored proteins are cell wall-localized, but there are also 
few in the plasma membrane (Richard and Plaine, 2007). Among the proteins with 
enzymatic activities in C. albicans both are found, GPI-anchor targeted to the cell wall and 
non-covalent secreted proteins. In order to determine the exact localisation of Sod5, we 
used a subcellular fractionation protocol. Using the monoclonal anti-GFP (Roche) 
antibody, we detected Sod5-GFP by Western blotting. This protocol enabled us to isolate 
in different steps proteins from the cell wall and the plasma membrane. Depending on the 
fraction that contains the protein we were able to identify the localization. Crude cell lysats 
were prepared after breaking cells without a centrifugation step, this fraction contains all 
proteins. Proteins not covalently linked to the cell wall were extracted in an SDS fraction. 
For the extraction of proteins linked to the β-glucans in the cell wall, we used digestion 
with laminarinase and zymolyase. Both enzymes are β-glucanases that are able to digest 
β-glucan linkages. GPI-anchored proteins are linked to β-1-6 glucans in the cell wall of C. 
albicans. Digestion with β-glucanases is a good way to determine if the protein is targeted 
to the cell wall or to the plasma membrane. Protein extracts were than separated on 12% 
SDS-PAGE gel. For the immunodetection the monoclonal anti-GFP antibody was used 
(Fig.III.2.11). 
 
 
 
Fig.III.2.11. Cellular fractionation protein extraction. In the first lane whole cell protein extract from the wild 
type, in the second lane whole cell protein extract from the PSOD5-GFP strain, in the following lanes the 
fractionation from Sod5-GFP strain after the wash with buffer containing 5mM DTT, the crude whole cell 
protein extract in the lane 4, lane 5 – supernatant obtained after centrifugation from the whole cell protein 
extractes, lane 6 – supernatant obtained after washing pellet in lysis buffer, lane 7 – pellet boiled with 2%SDS, 
lane 8 – supernatant obtained after incubation of pellet with laminarinase, lane 9 – pellet boiled with sample 
buffer.  
We were able to detect the protein in crude cell fraction and a small amount in 
the supernatant from this fraction. The largest amount of protein was isolated after boiling 
all pellets with 2%SDS, whereas we were unable to detect protein after digestion with 
laminarinase. These results suggest that Sod5 is localised in the cell wall and is either 
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non-covalently bound to the cell wall or belongs to the small number of cell wall proteins 
that can be extracted from the glucan mesh simply by boiling with SDS.  
 
5. Tunicamycin treatment 
 
A common modification of plasma membrane proteins is glycosylation. GPI-
anchored proteins are often glycosylated as well as mannosylated. To check Sod5 for 
glycosylations, we treated it with tunicamycin. Tunicamycin is an inhibitor of N-
glycosylation that works by inhibition of N-acetylglycosamine-1-phosphate transfer to 
dolichol monophosphate (Kuo and Lampen, 1974). It prevents attachment of N-glycosidic 
carbohydrate side chains to the proteins and it also inhibits GPI-anchor 
glycosylation/formation. On our immunoblots, we expected to get a slower migrating form 
of protein by cells with out tunicamycin treatment and another form of protein that is not 
glucosylated after treatment and is able to migrate easier through the gel. The expected 
molecular mass of the Sod5-GFP fusion protein is about 51kDa, formed of the predicted 
Sod5 molecular weight of 23,6kDa and GFP molecular weight of 27kDa. 
As expected, the results showed two isoforms of protein. Protein from the cells 
without tunicamycin treatment migrated at about 70kDa, whereas protein from the cells 
treated with tynicamycin showed isoform of a protein that was about 55kDa (Fig.III.2.12).  
This result confirm the suggestion of Sod5 to be a highly glycosylated protein.  
 
Fig.III.2.12. Tunicamycin from Streptomyces sp. (1µg/ml) treated Sod5-GFP protein extracts. 
Lane1: PSOD5-GFP; lane2: KY-Ca010 clone8.8 not treated; lane3: KY-Ca010 clone8.8 treated; lane4: KY-
Ca010 clone 6.10 not treated; lane5: KY-Ca010 clone 6.10 treated; Proteins treated with tunicamycin showed 
a shift in mobility, the mass of proteins was about 55kDa. 
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III.3. Production of anti-Sod4, anti-Sod5 and anti-Sod6 antibodies  
 
1. Cloning of antigens, expression of GST-Sod fusion protein in E.coli 
To have more biochemical tools to study C. albicans extracelluar SODs, we 
wanted produce polyclonal antibodies against Sod4, Sod5 and Sod6 proteins, therefore 
we constructed GST-Sod fusion proteins for antibody production of our three proteins of 
interest, Sod4, Sod5 and Sod6 from C. albicans. We compared the sequence of those 
proteins and studied the folding of proteins and secondary structures using diverse 
antigenic prediction programs. We used area of proteins, predicted to be on the surface 
and thus have antigenic properties. Since all three proteins are homologous and show 
high sequence similarities we used a certain domain of each protein as antigen source. 
We were restricted to the areas, which are different between these proteins to avoid cross 
reactions of anti-sera. 
For expression of Sod4, Sod5 and Sod6 proteins as GST fusions in bacteria, 
we chose 56-59 amino acids from each protein fused in frame to the C-terminus of GST. 
The fragments were generated by PCR using the primers S5_2TBamHIs and 
S5_2TXEcoRIas (corresponding names for Sod4 and Sod6). We introduced two 
restriction sites into this fragment BamHI on N-terminus and EcoRI on C-terminus of 
fragment. We used the pGEX-5x2 plasmid (see Appendix) and fused the SOD peptide 
behind GST. Using this vector with GST-Sod-fusion protein localized behind lac-operon, 
we were able to induce the expression of protein and purify large amounts of this protein.  
S odlacI Ampic illinGST
 
 
Fig.III.3.1. Schematic image of the construct that was used for expression and purification of GST-Sod-fusion 
protein. Expression of GST-Sod protein was induced by adding of IPTG to the media.  
 
Afterwards the fragments were ligated into pGEMT-easy vector. The ligation 
was performed according to the protocol in Materials and Methods and products were 
transformed into competent DH5α E.coli. Selection occurred on LB-Amp plates containing 
IPTG and X-Gal. IPTG-inducible promoter in pGEMT-easy plasmid allows the blue-white 
selection of transformants. We isolated the plasmid DNA from positive colonies, digested 
it with BamHI and EcoRI enzymes. The fragment was cloned into pGEX5x-2 vector that 
was also digested with the same enzymes (data not shown). The new ligation reaction 
was transformed into competent E.coli. Obtained colonies were tested on next day by 
colony-PCR. The constructs were sequenced and those without any mutations used 
further.  
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The constructs were used for the expression of GST-fusion protein expression. 
GST-fused peptide is localized behind the IPTG inducible promoter. The induction of 
promoter leads to expression of protein. First, to determine the optimal induction time, 
samples were taken after different time points of induction (0’, 20’, 40’, 60’, 90’, 120’ and 
180 min). Proteins were separated in 12% SDS-PAGE gels (Fig.III.3.1). 
 
 
Fig.III.3.1. The expression of GST-fusion 
proteins after the induction of promoter. 
Sod5-GST on the first gel, Sod4-GST on 
second and Sod6-GST on the third gel and 
pGEX5x-2 vector allow on the fourth gel. 
Samples were taken at time point 0 and 
then after 20, 40, 60, 90, 120 and 180 min. 
Expression of protein increased with the 
time. 
 
To determine if GST fusion proteins are soluble or not, cells were broken after 
the induction of protein expression and aliquots from pellet and supernatant were 
compared. Proteins were again separated on a 12% SDS-PAGE gels.  
 
 
  
Fig.III.3.2. After comparison of soluble phase and pellet we determined Sod4 and Sod5 as soluble and Sod6 
as not soluble proteins. The main amount of Sod4 and Sod5 proteins could be found  in the soluble fraction.  
 
Comparison of pellet and supernatant fractions in Commassie-stained SDS-
PAGE gels showed that most of the fusion proteins Sod4 and Sod5 were soluble. Sod6 
was insoluble; therefore an alternative method for purification was used (inclusion body 
purification).  
We purified Sod4 and Sod5 fusion proteins with glutathion sepharose beads  
from 500ml bacterial culture. The expression of GST-fusion protein was induced by 
adding of 0,2mM IPTG for 80min. Cells were broken by sonication in TpG and DTT. The 
supernatant was incubated with glutathion sepharose beads overnight. Next morning 
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protein bond to sepharose beads could be eluted after incubation with the elution buffer by 
room temperature. After exchanging the buffer to PBS, the purified proteins were used for 
rabbit immunisation.  
 
2. Immunisation procedure of rabbits  
Before immunization, pre-immune sera of the rabbits were tested by 
immunoblotting for pre-existing antibodies against C. albicans proteins. TCA-extracts of 
SN152 were separated in a 10% SDS-gel and immunoblotting was carried out using 
different dilutions of pre-immune serum (1:10, 1:50, 1:250, and 1:1000 in blocking milk) 
(Fig.III.3.3). 
A.  
B.  
 
 
Fig.III.3.3  
A. Preimmune serum from rabbits 
tested on hyphae protein extracts in 
different dilutions 1:10, 1:50, 1:250 
and 1:1000. A signal was only 
obtained at the 1:10 dilution by all 
three rabbits. The higher dilutions 
showed no recognition of protein 
extracts by preimmune sera. 
 
B. Preimmune serum from rabbits 
tested on yeast protein extracts in 
different dilutions 1:10, 1:50, 1:250 
and 1:1000. A signal was only 
obtained at the 1:10 dilution by two of 
three rabbits. The higher dilutions 
showed no recognition of protein 
extracts by preimmune sera.  
 
 
 
 
The rabbits showed cross-reaction with fungal proteins only at the lowest 
dilution (1:10). No cross-reactions were detected in all other dilution; therefore the rabbits 
were used for immunization with the GST-Sod fusion proteins. 
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For the primary injection, we used 500µg of the purified GST-fusion protein 
mixed with an incomplete Freund’s adjuvant (IFA). Boosting was carried out every 3-4 
weeks. See schedule of the immunization protocol. After the second boost, the first sera 
were tested for the presence of anti-Sod antibodies.  
 
Injection/ 
boosts Date 
Amount 
injected 
Days Bleeds Date 
Primary 
injection 
29.08.08 500µg    
   18   
1st boost 16.09.08 250µg    
   29   
2nd boost 15.10.08 125µg    
   28 1st 31.10.08 
3rd  boost 13.11.08 125µg    
   34 2nd 1.12.08 
4th boost 18.12.08 130µg    
   21 3rd 8.01.09 
5th boost 8.01.09 100µg    
   32 4th 10.02.09 
6th boost 10.02.08 50µg    
   21 5th 5.03.09 
7th boost 03.03.09 
20µg 
IV 
   
    final 30.03.09 
 
Table III.3.1: Immunization schedule 
Figure shows the date of every immunisation/ boosting, and the amount of antigen used for injection 
mmunisation. The amount of protein was determined using Bradfort method. We used a decreasing amount of 
antigen for every next boosting.  
 
Figure III.3.4 shows anti-sera of the first bleed tested for the antigen 
recognitions. Antigen (GST-fusion with one of the SOD proteins) was separated on the 
10% SDS-PAGE gel and incubated with different dilution (1:200; 1:500, 1:1000) of the 
serum from the rabbits. For the Western blot analysis we used MiniProtean II Multiscreen 
Apparatus (Bio-Rad). The purified antigen was loaded into the gel. Blotting was carried 
out as usual and the incubation with the sera occurred in the channels of the Multiscreen 
Apparatus, which allowed us to use economical amaonts of the sera and test different 
dilution on one membrane. We detected a signal against the antigen in the first sera taken 
from the rabbits. Futhermore, the recognition signal was depending on the dilution. 
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Fig.III.3.4 For the Western blot analyses we used 
MiniProtean II Multiscreen Apparatus (Bio-Rad) 
(described in Materials and Methods). 800ng of each 
purified fusion protein have been loaded in the 10% 
SDS-PAGE gel. After blotting, membranes were 
uncubated with the different appropriate dilutions 
(1:200, 1:500 and 1:1000) of bleed 1 taken from 
rabbits immunized with Sod4- Sod5- or Sod6-GST 
fusion proteins. Sera were tested for the recognition 
of antigen.  
 
 
To proof the stability of the antibodies, we tried different freezing conditions for 
the antibodies. The sera were frozen at -20°C, at -80°C and dry frozen and used 
afterwards for Western blot analysis. We detected no differences between the sera frozen 
under the different conditions. The antibodies in the sera were stable (Fig.III.3.5).  
 
 
 
 
 
 
 
GST 
 
 
 
 
 
Sod4 
 
 
 
 
GST 
 
 
 
 
 
Sod5
Fig.III.3.5 Sera were frozen
under the different condition
and used for detection in order
to determine the quality of
sera after freezing. Aliquots
were frozen at -20°, -80° or
dry frozen and then used for
detection of antigen. 1µg of
recombinant proteins digested
with FactorXA is loaded into
the gel. No differences
between aliquots handled
under different conditions
were detected.    
 
 
Sera from each bleed were tested for the antibodies against Sod proteins on 
TCA or whole cell protein extracts. The proteins extracted from the wild-type and from the 
sod4/sod5/sod6Δ/Δ deletion strains were separated on the 12% SDS-PAGE gel and 
incubated with the polyclonal sera diluted 1:1000. We were unable to detect a specific 
recognition of Sod proteins. All three sera recognized unspecific proteins on protein 
extracts in the size between 40 and 70kDa in wild-type and in knock-out strain (Fig.III.3.6). 
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Fig. III.3.6. Sera from bleed IV, used for immunobloting with protein extracts. Sera were tested in different 
dilutions. There are wild-type and sod4/sod5/sod6Δ/Δ strain protein extracts loaded in alternation. Using the 
sera we detected signals in wild type and in deletion strains suggesting the unspecificity of the sera.   
 
The seventh boost was carried out by the intravenous injection of 20µg of the 
protein. After the seventh boost we decided to end the immunisation of rabbits. The titers 
of antibodies did not significant increase anymore and we still did not obtain specific 
signals.  
 
 
3. Indirect immunofluorescence of C. albicans 
The anti-Sod5 antibodies were also tested for their ability to recognize Sod5 
protein via indirect immunofluorescence. Therefore, C. albicans wild type and 
sod4/sod5/sod6Δ/Δ mutant strains were immobilized on concanavalinA coated glass 
slides, fixed with paraformaldehyde and stained with the polyclonal rabbit anti-Sod5 
antibodies followed by anti-rabbit Cy5-conjugated secondary antibodies. We used two 
different dilutions of rabbit sera (1:100; 1:200) for the immunofluorescence. Moreover, we 
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performed additional calcoflour white-staining to visualize chitin in the cell wall (Molano et 
al., 1980; Roncero and Duran, 1985). We detected a signal from the anti-Sod5 antibody 
stained-cells in wild type and in deletion strain (Fig.III.3.7). Anti-Sod5 antibodies 
recognized the whole cell wall of C. albicans. 
Unfortunately, we did not detect any specific signals with the three polyclonal 
sera (data not shown). In the case of a specific recognition, we would expect detection of 
proteins in the wild type but no recognition on deletion strains. No staining was observed 
with the pre-immune sera (data not shown). All three polyclonal antibodies were 
unspecific and recognized proteins in the cell wall C. albicans sod4/sod5/sod6Δ/Δ deletion 
strain. We saw no difference between the recognition of both strains by the antibodies. 
 
 Cy5 Calcofluor white Transmission 
 
 
 
wild type 
 
 
 
 
sod4/sod5/sod6Δ/Δ
 
Fig.III.3.7. Indirect immunofluorescence of C. albicans. Indirect immunofluorescence staining was 
performed as described in Materials and Methods. Sera were diluted 1:100. Wild type and deletion strains 
were used for immunofluorescence. Additional to antibody cells were also stained with Calcofluor white. Lane 
1: wild type cell; lane2: sod4/sod5/sod6Δ/Δ deletion strains. Slides were observed in Cy5, DAPI and contrast 
phase filters.  
 
4. Affinity purification of anti-Sod4 and anti-Sod5 sera 
 
Affinity purification is a procedure that is often used to purify antibodies from 
the serum. After the incubation of our sera with protein extracts we obtained several 
signals that were unspecific recognition. We performed affinity purification to select the 
antibodies that recognize specifically the GST-fusion protein.  
Therefore, GST-fusion proteins were separated in the 12% gel. After the 
transfer to the nitrocellulose membrane the band of interest was cut out and used for the 
incubation with the serum. In this step, only the antibodies that specifically recognize 
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antigen should bind. The antibodies were eluted from the membrane using 100mM Glycin 
pH2,5 and neutralized immediately by adding 1M Tris/HCl pH8.0. 
The purified antibodies were tested for the quality on a Western blot and used 
for immune fluorescence microscopy. The results for anti-Sod5 affinity purification are 
shown in Figure III.3.8. We were able to purify anti-Sod5 antibodies. All three eluates, 
obtained during elution of antibodies bound to the antigen, were tested fore their 
concentration and fore their ability to recognize the recombinant antigene. In all eluates, 
the purified antibodies were still able to recognize the antigen and the concentration of 
antibodies was high enough to use them for Western blot and immunofluorescence 
experiments.  
 
Fig.III.3.8 Affinity purification of anti-Sod5 antibody. Recognition of GST-Sod5 fusion protein (1µg protein 
loaded into the gel) by the anti-Sod5 (bleed4), by the obtained during purification eluates and by the 
supernatant remaining afterwards. In contrast no recognition of the antigen by preimmune serum was 
detected. Two different concentration 1:1000 and 1:500  were used, the signal by the higher concentration of 
the antibody is stronger. For the Western blot analyses we used MiniProtean II Multiscreen Apparatus (Bio-
Rad). 
 
Affinity purified anti-Sod5 antibodies were used for immunofluorescence. Even 
with affinity purified antibodies, we were unable to detect specific signals. Antibodies 
recognized the whole C. albicans cell surface. Moreover, the signals detected on the wild 
type C. albicans and on sod4/sod5/sod6Δ/Δ strains were of comparable intensity. Hence, 
the signal obtained with anti-Sod5 antibodies were not a cross-reaction with one of other 
Sod proteins located on the surface of the C. albicans cell (Fig.III.3.9). 
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Fig.III.3.9. Indirect immunofluorescence of C. albicans. Indirect immunofluorescence staining was 
performed as described in Materials and Methods. Sera were diluted 1:100. Wild-type and deletion strains 
were used for immunofluorescence. Additional to antibody cells (secondary antibody anti-rabbit Cy5-
conjugate) were also stained with Calcofluor white. Lane 1: wild type cell; lane2: sod4/sod5/sod6Δ/Δ deletion 
strains. Slides were observed in Cy5, DAPI and contrast phase filters.  
  
 
5. Immunization procedure of mice. Characterisation of mice antibodies 
 
C. albicans is known to be a commensal in human and some animals. For 
example, C. albicans is a commensal in rabbits but not in mice. Considering this, we 
decided to use the same antigen, GST-fused Sod peptide to immunize mice. We expected 
the mouse immune response to be more specific for the antigen. Four mice were used for 
immunization, two for anti-Sod4 antibody production and two for anti-Sod5 (see Fig.III.310 
immunization schedule). 
 
Immunisation Date Amount Days Bleeds Date 
Immunisation 9.07.09 50µg    
   11   
1st boost 20.07.09 50µg    
   10 1. bleed 23.07.09 
2nd boost 30.07.09 50µg    
    2.bleed 3.08.09 
 
 
 
 
 
 
Fig.III.3.10. Immunization schedule of the mice. Mice were immunized each time with 50µg of the antigen. 
The amount of the antigen was determined by Bradford method (described in Materials and Methods).  
 
72 
 
After the immunization and the first boost, the first bleed was collected from 
the immunized animals. The polyclonal sera were tested for the presence of specific 
antibodies.  First, we performed a Western blot and tested mouse sera for the antigen 
recognition. However, we were unable to detect any antigen recognition with the first 
bleed (Fig.III.3.11).  
 
A.  B.  
 
Fig.III.3.11. Mouse bleed1 tested for the antigen recognition 
A. GST-Sod4 fusion protein digested with Factor Xa protease (1µg protein loaded into the gel) was tested 
for the recognition by anti-Sod4 antibody. Lane1: preimmune serum from mouse No.1; lane 2: preimmune 
serum from the mouse No.2; lane 3: first bleed mouse No.1; lane 4: first bleed mouse No.2.  No 
recognition of antigen was detected.  
B. GST-Sod5 fusion protein digested with Factor Xa protease (1µg protein loaded into the gel) was tested 
for the recognition by anti-Sod5 antibody. Lane1: preimmune serum from mouse No.1; lane 2: preimmune 
serum from the mouse No.2; lane 3: first bleed from the mouse No.1; lane 4: first bleed mouse from the 
mice No.2 immunized with Sod5-GST fusion protein. Dirt on the right side of the figure on the blot 
incubated with preimmune serum is probably coming because of bad quality of the serum which was 
already coagulated.   
 
For this reason, we boosted animals and then tested the next bleed. In our second bleed 
we had already antibodies inside against the antigen. We detected a clear and strong 
recognition of GST-fusion protein by the immune serum (data not shown). Since we had 
an immune response, we tested the sera obtained from immunized mice on protein 
extracts. Again no specific recognition was seen. We obtained the same signals on 
protein extracts from the wild type and from the triple deletion strain (for details see 
chapter below). Sera obtained from mice immunized with GST-Sod4 or GST-Sod5 fusion 
proteins were unspecific. 
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The second serum was also used for indirect immunofluorescence, but we 
were unable to detect any specific immunodecoration of fungal cells (data not shown). 
Antibodies recognized the C. albicans surface unspecifically. The signal obtained in wild 
type and sod4/sod5/sod6Δ/Δ deletion strains was similar. The result was the same as 
already obtained on Western blot. Antibodies recognized several unspecific proteins. 
Based on these results, we decided to stop the immunization procedure. Compared to the 
second bleed, the final (third) bleed contained more antibodies. The signals on Western 
blots were stronger (by the same dilution 1:1000), but again only unspecific bands 
(Fig.III.3.12). TCA extracts from the wild type and the sod4/sod5/sod6Δ/Δ deletion strain 
were loaded into the SDS-PAGE gel in alteration (Fig.III.3.12) and incubated with the final 
mouse bleed from the four mice used for immunization. We detected only unspecific 
recognition of proteins from both strains. The immune response was different between the 
mice immunized with the same antigen; so the mouse #2 immunized with Sod5-GST 
fusion protein showed more unspecific immune response compared to the mouse #1.  
 
Fig.III.3.12. Final mouse bleed on protein TCA extracts from the wild type and sod4/sod5/sod6∆/∆ 
deletion strain. TCA protein extracts from the wild type and sod4/sod5/sod6∆/∆ deletion strain are loaded in 
alternation. Protein extracts from both strains were incubated with the final bleed with anti-Sod4 and anti-Sod5 
antibodies. 
 
 No specific signals were detected. The sera from the immunized animals 
seam to recognize a lot of different proteins. But we obtained no signal by the wild type 
protein extracts which is not detectable in deletion strain protein extracts. The results 
obtained from the mice immunization were similar to those obtained from the immunized 
rabbits. 
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IV. Discussion 
 
The recognition of microbial pathogens by cells of the innate immune system 
leads to phagocytosis of pathogens and increased ROS production (Dinauer, 1993)  
Somehow, C. albicans is able to survive and to destroy phagocytes through filament 
formation inside the phagosome. Sod5 plays important role in protection of C. albicans 
against extracellular stress (Fradin et al., 2005; Frohner et al., 2009). C. albicans strains 
lacking SOD5 are attenuated in their virulence and have a decreased survival rate in 
coculture with BMDMs (Frohner et al., 2009).  Sod5 is an important enzyme in C. albicans 
involved in degradation of extracellular ROS produced by macrophages. We are 
interested in showing the cellular localisation of this protein by applying two different 
methods: tagging of Sod5 with GFP and production of antibodies against this protein. We 
proved the induction of SOD5 promoter under different conditions using PSOD5-GFP 
construct. During my diploma thesis, I was able to successfully tag Sod5 with a GFP. 
Furthermore, a strain with internal tagged Sod5 was used for localisation studies. 
 
 
1. Promoter activity studies 
 
 
The promoter, a sequence located upstream of the open reading frame, is 
responsible for the transcription of the target genes. Studies about the regulation and 
activity of a promoter give us evidence about the expression of a target gene. Reporter 
genes are mainly used to study the promoter regulation. The reporter gene is fused to the 
promoter of interest and promoter activation results in expression of a reporter gene. This 
is a very sensitive technique and is widely used for the studies of transcriptional regulation 
(Xue et al., 2007). Fluorescent and luminescent proteins are often used as reporter genes. 
Common reporter genes are Green Fluorescent Protein (GFP), Luciferase, β-
Glucuronidase, β-Galactosidase.  
For our experiments we decided to use Fluorescent proteins such as GFP, 
YFP and CFP from pMG1646, pMG1656 and pMG1801 plasmids (kindly provided by J. 
Berman). We used strains with constitutive expressed GFP and GFP expressed under 
SOD5 promoter and in this way are able to compare the activity of both promoters and to 
study the induction conditions of SOD5 promoter.  
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We tested different condition for the promoter induction. We are able to show 
the increased SOD5 transcription at 37°C in the presence of serum, suggesting that 
serum and temperature are factors that regulate the expression of SOD5. This means that 
C.albicans enzyme Sod5 is active during yeast to hyphae transition, which is a an 
important switch for the virulence of the fungus, since the yeast forms are less virulent (Lo 
et at.,1997). Our results confirm the data of previous publications. Martchenko et al 
showed the up regulation of SOD5 promoter during yeast-to-hyphae transition using 
Northern blot method (Martchenko et al., 2004).  
We show highest up-regulation of SOD5 under osmotic stress condition. Using 
yeast media with pH8 and 0,3M NaCl, we are able to induce the expression of SOD5 
gene and detect the highest signal on Western blot using an anti-GFP antibody for our 
reporter gene. SOD5 seams to be one of more than 100 other genes (Enjalbert et al., 
2003) that are induced in C.albicans in response to oxidative and hyperosmotic stress. 
During osmotic stress conditions the activation of promoter is even higher than during 
yeast to hyphae transition. SOD5 is expressed in phagocytosed cells (Fradin et al., 2005). 
During the phagocytosis, a pH is changing, after the fusion of phagosome with a lysosome 
a pH decrease and then increase to pH 7,8. The pH change in the media may mimic the 
phagosomal environment and so give a rise for a SOD5 expression. This may explain a 
high SOD5 expression under the osmotic and pH stress conditions.  
 
2. Studies of Sod5 localization  
 
The functional Sod5-GFP is used to study the cellular localization of the 
protein. First, we detected this protein under the fluorescent microscope. Further, we used 
Sod5-GFP strain stained with filipin for the microscopy. Filipin is an antibiotic able to form 
a complex with the free 3-β-hydroxy sterols in the plasma membrane. Using this method, 
we tried to determine the localisation of the Sod5-GFP comparing this signal to the filipin-
stained plasma membrane. There are some problems in the work with filipin. Filipin is 
unstable; the solution for filipin staining should be prepared fresh. Filipin bleached very 
fast, therefore the microscopy picture have to be taken very fast. Filipin can also deform 
membranes, because of the toxicity to the cell (Alvarez et al., 2007). However, filipin is a 
common method to stain the plasma membrane.  
We stained C. albicans cells and visualized them by fluorescence microscopy. 
We detected signals from the filipin-stained plasma membrane and from the Sod5-GFP 
protein. But we are unable to distinguish whether the Sod5-GFP signal is coming from the 
cell wall or plasma membrane. Confocal microscopy would be a way to distinguish 
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between those two signals; we used a confocal microscope for our experiment. However, 
the filipin staining was very weak and breached before we were able to take a picture. 
Thus, we are able to visualize Sod5 protein by fusion with GFP and we are able to 
detected Sod5-GFP protein in the fluorescent microscope after the induction of protein 
expression, but we are unable to conclude the exactly localization of the protein.  
For the detection of protein by Western blot analysis, we use a protein isolation 
protocol for C. albicans that allows us to isolate proteins in different steps (in different 
fractions) to determine the localization (Mao et al., 2003). Proteins that localise to the 
plasma membrane should be extracted after breaking the cells and go into the 
supernatant. First of all, proteins that are not covalently bound to the cell wall, but also 
some GPI anchored proteins can be isolated in this way. Proteins that are localised in the 
cell wall are extracted either with 2% SDS and boiling by 95°C or by digestion with ß-
glucanase.  
We are able to detect the biggest amount of Sod5-GFP protein in the SDS-
extractable fraction, after the pellets of broken cells are boiled with buffer containing 2% 
SDS. Under these conditions the proteins that are not covalently linked to the cell wall can 
be extracted. There is also evidence from S. cerevisiae that some cell wall proteins can be 
extracted with SDS (Terashima et al., 2002) and also some GPI-anchored cell wall 
proteins can be extracted under these conditions (Shankarnarayan et al., 2008). This 
leads us to conclusion that C. albicans Sod5 is located in the cell wall and is probably not 
covalently linked to it.  
Tunicamycin treatment shows that Sod5 is a highly glucosylated protein. By 
blocking of glycosylation by tunicamycin we detect Sod5-GFP protein on Western blot 
migrating at about 55kDa. This corresponds to the predicted weight of Sod5 protein, which 
is about 24kDa and the weight of GFP protein (27kDa). Sod5-GFP protein isolated from 
the cells with out tunicamycin treatment migrates at about 70kDa.  
 
 
3. Production of antibodies  
 
During my work, I tried to produce specific antibodies against the three C. 
albicans proteins Sod4, Sod5 and Sod6. Since all SODs are highly conserved and have a 
big similarity, the raising specific antibodies is a difficult task. For the production of 
antibodies we had to identify regions with antigenic properties in these proteins. Therefore 
we use antigenic prediction programs and compare the proteins for homology to exclude 
the cross reactions. For expression of proteins in E.coli and purification, we use an 
established lab protocol, which worked fine.  
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Unfortunately, the antibodies are not specific. On Western blot the antibodies 
recognize antigens, but they show cross reactions to each other and no recognition of the 
SODs in protein extracts. We are able to detect an increase of immune response after 
each next boost, but we have no specific recognition for anyone of the three Sod proteins. 
Since in the rabbit sera we have the antibodies that are able to recognize the 
antigen, we performed affinity purification to select specific antibodies. Using the purified 
sera we are unable to detect any proteins on Western blot; used for indirect 
immunofluorescence in C. albicans we obtain again signal from the unspecific recognition 
in wild type cells and in deletion strain. So, even after affinity purification antibodies are 
not specific.  
For the following immunisation constructs it may be useful to consider this and 
try to use peptides or other protein regions (maybe whole protein) for immunisation. 
Animals can be immunized with native proteins, peptides, or any other compound of 
fungal origin. A recombinant protein can be expressed in E.coli in high levels, but it may 
be improperly folded and not resemble the native protein with post-translational 
modifications. Therefore it may be important to switch to eukaryotic expression vector 
system. GST part  of  fusion protein is also known to trigger a strong immune response, in 
this case it may also be useful  to digest GST from the peptide and use only the peptide 
for immunisation. Since in some cases the high doses of antigen may lead to immune 
tolerance instead of immune response, the right amount of antigen for immunization is 
very important. Therefore, we should work on improving the immunization procedure and 
maybe try to start the immunization with smaller amount of antigen.  
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V. Appendix 
1. Primers, strains and plasmids used for this study 
Name 5’-3’ 
M5s ccgctgctaggcgcgccgtgACCAGTGTGATGGATATCTGC 
M3as gcagggatgcggccgctgacAGCTCGGATCCACTAGTAACG 
  
55_caSOD4s CAGCATAAACCAAATAACATTACTC 
53_caSOD4as cacggcgcgcctagcagcggCATAGTAATAGTGTGTGTGATTAAAAATC 
35_caSOD4s gtcagcggccgcatccctgcTAGATAGAGAATAACTAGAACAATCAAATG 
33_caSOD4as CTTGAAAAAATATCATTAAGTGAACG 
  
55_caSOD5s CACGGCTGAGAGGTCACTAC 
53_caSOD5as cacggcgcgcctagcagcggCATGATGAATGGTAAGTTAGATTG 
35_caSOD5s gtcagcggccgcatccctgcAGATGAGCCATTTTACTTATTGTG 
33_caSOD5as CATGTCTGTATAGGATAATGAAAGTG 
  
55_caSOD6s GCTTGGTAGTGGTGGACTAGAG 
53_caSOD6as cacggcgcgcctagcagcggCATCTTGCTGAGACGTTTAGTG 
35_caSOD6s gtcagcggccgcatccctgcTAGTTGAACATAAATACTCTCACCC 
33_caSOD6as CGATTCAGAGCTTGAGATTGAG 
  
5_SOD4s AACCTCCTAAACGCAACTGC 
3_SOD4as GAACCAAGGAAGCATTGCC 
  
5_SOD5s CGGCAATTGATTACGACAAG 
3_SOD5as CTCACGTTTGCTTCTCGC 
  
5_SOD6s GAGGCATCTGTTGCTTCCAC 
3_SOD6as CGGTAGACTATTTGTCATTGGTG 
  
pSFS2a vector 
primer 
 
SAT7s GAAGTGTTCGATGTGCACCTATCC 
SAT108as CTCCATCACCCAGTTTAGTTGTACC 
SAT101as Ggtacaactaaactgggtgatggag 
SAT101s CTCAAGTCTCGAACGAAACAG 
  
internal primer  
SOD6_1s Atgatctttattcccattatcat 
SOD6_2s GATCTTTATTCCCATTATCATATTAATC 
Sod6_232s CATATACATGAACGGTCTGTTC 
RTSod6_339s CTACTGTCAAGTGGGCGACTTGC 
Sod6_644s CATCGGAAATTTACCATTCTG 
Sod6_166as CTTCTTTAGCACTAAACACCAC 
RTSod6_806as GTTCTGGTCGCTGGGCCTAG 
Sod6_951as CTAAACAAATATTCCTGCAGC 
  
Sod5_1s ATGAAGTATTTGTCCATTTTCTTAC 
Sod5_49s GATGCACCAATCTCAACTG 
Sod5_631s GTAGTAAATGGTCTCTTGGC 
Sod5_65as GTTGAGATTGGTGCATCAC 
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Sod5_676as CAGCAATGACACCAACTAC 
Sod5_687as TTAAATCAAGGCAGCAATGAC 
  
SOD4_1s ATGAAATACTTGTCTATTATTTCAATTG 
Sod4_9s CTTGTCTATTATTTCAATTGTTGC 
Sod4_699as CTAAATTAAAGCAGCAACAACAC 
Sod4_286as GATTAAAGTGCATACCTGTAGC 
Sod4_551s CTTCTTCTTCTTCGTCATCATC 
  
CA  ACT1  
ACT1_s ATGGACGGTGGTATGTTTTAGT 
ACT1_as CAGAAGATTGAGAAGAAGTTTGC 
5_CaAct1s GTTGTTGTTGTGGGTGTGTG 
3_CaAct1as GGAATGAATGGGATGAATCATC 
YFP_100as TCACCTTCACCGGAGACAG 
His_794s GGACTGGGTTGCCATCTC 
  
Ca Actin 
tagging 
 
F1.1 CaActs ActcctggttttctttctttcttagaaacattatctcgatattaatattaaaaaaatataatcattcaaaatgT
CTAAAGGTGAAGAATTATTCAC 
R2 CaActas ATATATGTAATAACAAAAAGAAGAATAACAAGAATACAAAACCAGATT
TCCAGATTTCCAGAATTTCACTGAATTCCGGAATATTTATGAGAAAC 
F1.1 CaSod5s AattgtccttatatctcaactctacactcttgttccacttaaattatatcaatctaacttaccattcatcatgT
CTAAAGGTGAAGAATTATTCAC 
R2 CaSod5as AGCCACAGAGTAATCTTGTACCTGTTTATCAAACACAATAAGTAAAAT
GGCTCATCTATTTTATTTTTCTGAATTCCGGAATATTTATGAGAAAC 
F1.1 CaSod4s TtcatctatgccttatttccttcctttttattcataaaacattagatttttaatcacacacactattactatgTC
TAAAGGTGAAGAATTATTC 
R2 CaSod4as TTTAATGAAAAATTGAATAACAACGTTTAATTAAATAGTGTATACATTT
GATTGTTCTAGTTATTCTCTAGAATTCCGGAATATTTATGAGAAAC 
F1.1 CaSod6s Tttaaaaatcgtcataataatcttgatcttcatatttttgtgaagatttatcactaaacgtctcagcaagatg
TCTAAAGGTGAAGAATTATTCAC 
R2 CaSod6as AAACATATATTGTGTTTTTTTTTTTCCCGCAATGGAAGATTACGTCCA
TAGGGTGAGAGTATTTATGTTCGAATTCCGGAATATTTATGAGAAAC
  
Antigene 
cloning 
 
S4_2TBamHIs ACGggatccGGTTCCACTACTGCCAAAACAC 
S4_XBamHIs ACGggatccATGGTTCCACTACTGCCAAAAC 
S4_2TXEcoRIas ACGgaattcGGAATGAACAACAATAGACAACCC 
  
S5_2tBamHIs ACGggatccGGAACCGTTAGAGCTGCAAC 
S5_XBamHIs ACGggatccATGGAACCGTTAGAGCTGC 
S5_2TXEcoRIas ACGgaattcGGCGTGAATTACAATTGATAAAC 
  
S6_2TBamHIs ACGggatccGCTAGTCCAGTTTGCGATGAAC 
S6_XBamHIs ACGggatccATGCTAGTCCAGTTTGCGATG 
S6_2TXEcoRIas ACGgaattcATAATGGAACACCACCGACTTTC 
  
pGST_seq1 CAATGTGCCTGGATGCG 
pGST_seq2 TTGTATGACGCTCTTGATGTTG 
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Sod5 internal 
tagging 
 
GFP-4s-Kas1     ACGGGCGCCTCTAAAGGTGAAGAATTATTCACTG 
GFP-727as-
Kas1  
ACGGGCGCCTTTGTACAATTCATCCATACCATG 
Sod5-Kas1-48as AGCGGCGCCACCAGCCAAAGCAAAAGTAG 
Sod5-Kas1-48s AGCGGCGCCGATGCACCAATCTCAACTGAC 
Sod5-Kas1-
575as 
AGCGGCGCCGACTGCACTTTGAGATG 
Sod5-Kas1-575s   AGCGGCGCCAACACTTCTTCTAGTATGGCTTCTAC 
  
55_caSOD5s CACGGCTGAGAGGTCACTAC 
SOD5_ct_Not as GAgcggccgcATTTTATTTTTCTTTTTTAAATCAAGGC 
FRT-S5term s ccggtacccaattcgccctatagtgagtcgtattacgcgcagatgagccattttacttattgtg 
33_caSOD5as CATGTCTGTATAGGATAATGAAAGTG 
FRT-f s gcgcgtaatacgactcactataggg 
  
pGEMT primer  
T7prom s Taatacgactcactataggg 
Sp6prom as Tatttaggtgacactatag 
TableV.1.1 Primer list 
 
 
Strains Short 
Names 
Genotypes References 
SN152 arg4∆/∆ 
leu2∆/∆ 
his1∆/∆ 
arg4∆/arg4∆, leu2∆/leu2∆, his∆1/his1∆, 
URA3/ura3∆ 
Noble, Johnson, 
2005  
SNR34R arg4∆/∆ 
leu2∆/∆ 
his1∆/∆ 
MTLa/a ,arg4∆/arg4∆, leu2∆/leu2∆, 
his∆1/his1∆,ura3∆-
iro1∆::imm434/URA3-IRO1 
 
CA-IF100 arg4∆/∆ 
LEU2 HIS1 
arg4∆/arg4∆, leu2∆/leu2∆::cmLEU2, 
his∆1/his1∆::cdHIS1, URA3/ura3∆ 
Frohner, 2009 
CA-IF019 sod5∆/∆ SN152, sod5∆::cmLEU2/sod5∆::cdHIS1 Frohner,2009 
CA-IF027 sod5∆/Δ 
SOD5 
SN152, 
sod5∆::cmLEU2/sod5∆::cdHIS1::SOD5-
FRT 
Frohner, 2009 
KY-Ca001 PACT-GFP SN152, ACT1/act1∆::GFP-HIS This study  
KY-Ca002 PACT-CFP SN152, ACT1/act1∆::CFP-HIS This study 
KY-Ca003 PSOD4-YFP SN152, SOD4/sod4∆::YFP-HIS This study 
KY-Ca004 PSOD6-GFP SN152, SOD6/sod6∆::GFP-HIS This study 
KY-Ca005 PSOD5-CFP SN152, SOD5/sod5∆::CFP-HIS This study 
KY-Ca006 PSOD5-GFP SN152, SOD5/sod5∆::GFP-HIS This study 
KY-Ca007 PACT-GFP SNR34R, ACT1/act1∆::GFP-HIS This study 
KY-Ca008 PACT-CFP SNR34R, ACT1/act1∆::CFP-HIS This study 
KY-Ca009 PSOD5-CFP SNR34R, SOD5/sod5∆::CFP-HIS This study 
KY-Ca010 Sod5-GFP 
(N-terminal) 
Clone 6.6;  
Clone 6.10;  
Clone 8.8; 
Clone 8.10 
CA-IF019, sod5∆::SOD5-
GFP/sod5∆::cdHIS1 
This study 
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KY-Ca010 Sod5-GFP 
(C-terminal) 
Clone 1.4; 
Clone 1.15; 
Clone 4.4; 
Clone 4.13 
CA-IF019, sod5∆::SOD5-
GFP/sod5∆::cdHIS1 
This study 
KY-Ca011 Sod5-GFP CA-IF100, SOD5/SOD5::SOD5-GFP This study 
TableV.1.2. Fungal strains used in this study 
 
 
 
pGEMT 
 
 
pGEMTeasy 
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pSFS2a 
 
 
pGEX5x2 
 pGEX-5x2 
vector used 
for protein 
expression 
 
 
 
pMG1646 
Berman 
plasmid 
83 
 
pMG1656 
Berman 
plasmid 
pMG1801 
Berman 
plasmid 
TableV.1. 3. Plasmids used for this study 
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